1
|
Matchett KP, Wilson-Kanamori JR, Portman JR, Kapourani CA, Fercoq F, May S, Zajdel E, Beltran M, Sutherland EF, Mackey JBG, Brice M, Wilson GC, Wallace SJ, Kitto L, Younger NT, Dobie R, Mole DJ, Oniscu GC, Wigmore SJ, Ramachandran P, Vallejos CA, Carragher NO, Saeidinejad MM, Quaglia A, Jalan R, Simpson KJ, Kendall TJ, Rule JA, Lee WM, Hoare M, Weston CJ, Marioni JC, Teichmann SA, Bird TG, Carlin LM, Henderson NC. Multimodal decoding of human liver regeneration. Nature 2024:10.1038/s41586-024-07376-2. [PMID: 38693268 DOI: 10.1038/s41586-024-07376-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2023] [Accepted: 04/02/2024] [Indexed: 05/03/2024]
Abstract
The liver has a unique ability to regenerate1,2; however, in the setting of acute liver failure (ALF), this regenerative capacity is often overwhelmed, leaving emergency liver transplantation as the only curative option3-5. Here, to advance understanding of human liver regeneration, we use paired single-nucleus RNA sequencing combined with spatial profiling of healthy and ALF explant human livers to generate a single-cell, pan-lineage atlas of human liver regeneration. We uncover a novel ANXA2+ migratory hepatocyte subpopulation, which emerges during human liver regeneration, and a corollary subpopulation in a mouse model of acetaminophen (APAP)-induced liver regeneration. Interrogation of necrotic wound closure and hepatocyte proliferation across multiple timepoints following APAP-induced liver injury in mice demonstrates that wound closure precedes hepatocyte proliferation. Four-dimensional intravital imaging of APAP-induced mouse liver injury identifies motile hepatocytes at the edge of the necrotic area, enabling collective migration of the hepatocyte sheet to effect wound closure. Depletion of hepatocyte ANXA2 reduces hepatocyte growth factor-induced human and mouse hepatocyte migration in vitro, and abrogates necrotic wound closure following APAP-induced mouse liver injury. Together, our work dissects unanticipated aspects of liver regeneration, demonstrating an uncoupling of wound closure and hepatocyte proliferation and uncovering a novel migratory hepatocyte subpopulation that mediates wound closure following liver injury. Therapies designed to promote rapid reconstitution of normal hepatic microarchitecture and reparation of the gut-liver barrier may advance new areas of therapeutic discovery in regenerative medicine.
Collapse
Affiliation(s)
- K P Matchett
- Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK
| | - J R Wilson-Kanamori
- Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK
| | - J R Portman
- Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK
| | - C A Kapourani
- Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK
- MRC Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK
- School of Informatics, University of Edinburgh, Edinburgh, UK
| | - F Fercoq
- Cancer Research UK Beatson Institute, Glasgow, UK
| | - S May
- Cancer Research UK Beatson Institute, Glasgow, UK
| | - E Zajdel
- Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK
| | - M Beltran
- Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK
| | - E F Sutherland
- Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK
| | - J B G Mackey
- Cancer Research UK Beatson Institute, Glasgow, UK
| | - M Brice
- Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK
| | - G C Wilson
- Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK
| | - S J Wallace
- Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK
| | - L Kitto
- Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK
| | - N T Younger
- Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK
| | - R Dobie
- Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK
| | - D J Mole
- Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK
- University Department of Clinical Surgery, University of Edinburgh, Edinburgh, UK
| | - G C Oniscu
- Edinburgh Transplant Centre, Royal Infirmary of Edinburgh, Edinburgh, UK
- Division of Transplant Surgery, CLINTEC, Karolinska Institutet, Stockholm, Sweden
| | - S J Wigmore
- Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK
- University Department of Clinical Surgery, University of Edinburgh, Edinburgh, UK
| | - P Ramachandran
- Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK
| | - C A Vallejos
- MRC Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK
- The Alan Turing Institute, London, UK
| | - N O Carragher
- Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK
| | - M M Saeidinejad
- Institute for Liver and Digestive Health, University College London, London, UK
| | - A Quaglia
- Department of Cellular Pathology, Royal Free London NHS Foundation Trust, London, UK
- UCL Cancer Institute, University College London, London, UK
| | - R Jalan
- Institute for Liver and Digestive Health, University College London, London, UK
- European Foundation for the Study of Chronic Liver Failure, Barcelona, Spain
| | - K J Simpson
- Department of Hepatology, University of Edinburgh and Scottish Liver Transplant Unit, Royal Infirmary of Edinburgh, Edinburgh, UK
| | - T J Kendall
- Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK
| | - J A Rule
- Department of Internal Medicine, University of Texas, Southwestern Medical Center, Dallas, TX, USA
| | - W M Lee
- Department of Internal Medicine, University of Texas, Southwestern Medical Center, Dallas, TX, USA
| | - M Hoare
- Early Cancer Institute, University of Cambridge, Cambridge, UK
- Department of Medicine, University of Cambridge, Cambridge, UK
| | - C J Weston
- NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, Birmingham, UK
- Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
| | - J C Marioni
- Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK
- European Molecular Biology Laboratory, European Bioinformatics Institute, Cambridge, UK
- Wellcome Genome Campus, Wellcome Sanger Institute, Cambridge, UK
| | - S A Teichmann
- European Molecular Biology Laboratory, European Bioinformatics Institute, Cambridge, UK
- Wellcome Genome Campus, Wellcome Sanger Institute, Cambridge, UK
- Department of Physics, Cavendish Laboratory, Cambridge, UK
| | - T G Bird
- Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK
- Cancer Research UK Beatson Institute, Glasgow, UK
| | - L M Carlin
- Cancer Research UK Beatson Institute, Glasgow, UK
- School of Cancer Sciences, University of Glasgow, Glasgow, UK
| | - N C Henderson
- Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.
- MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
| |
Collapse
|
2
|
Matres A, Carballo N, Bernabé Y, Martínez A, Silverio A, Depares I, Cidoncha I, Beltran M, Braña I, Élez E, Díez M, Muñoz E, Saura C, Oaknin A, Macarulla T, Carles J, Felip E, Tabernero J, Garralda E, Pérez-Pujol S. Transition to the new EU CTIS Portal for Regulatory Clinical Trial Submissions: VHIO’s Start-Up Unit Analysis. Eur J Cancer 2022. [DOI: 10.1016/s0959-8049(22)00928-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
3
|
Bardaji ML, Aliende E, Moreno M, Oberoi H, Braña I, Saavedra O, Villar MV, Alonso G, Galvao V, Carballo N, Beltran M, Rovira P, Cidoncha I, Manich CS, Mercade TM, Oaknin A, Galceran JC, Felip E, Garralda E, Pujol SP. 1623P Phase I clinical trials (CT) forge on despite COVID-19. Ann Oncol 2021. [PMCID: PMC8454387 DOI: 10.1016/j.annonc.2021.08.1616] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
|
4
|
Beltran M, Schibille N, Gratuze B, Vallcorba O, Bonet J, Pradell T. Composition, microstructure and corrosion mechanisms of Catalan Modernist enamelled glass. Ann Ital Chir 2021. [DOI: 10.1016/j.jeurceramsoc.2020.10.041] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
5
|
Beltran M, Carrillo-Martin I, Gil Y, Gonzalez-Estrada A. M014 EOSINOPHILIA RELATED TO NIVOLUMAB: ALLERGY OR A HELPFUL ALLY. Ann Allergy Asthma Immunol 2019. [DOI: 10.1016/j.anai.2019.08.092] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
6
|
Gil Y, Carrillo-Martin I, Beltran M, Sluzevich J, Gonzalez-Estrada A. M157 REFRACTORY ANTIHISTAMINE-RESISTANT CHOLINERGIC URTICARIA UNRESPONSIVE TO OMALIZUMAB. Ann Allergy Asthma Immunol 2019. [DOI: 10.1016/j.anai.2019.08.157] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
7
|
Ayache S, Beltran M, Guevara N. Endoscopic transcanal myringoplasty for anterior tympanic membrane perforation. Eur Ann Otorhinolaryngol Head Neck Dis 2019; 136:413-415. [DOI: 10.1016/j.anorl.2019.05.001] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
8
|
Ayache S, Beltran M, Guevara N. Endoscopic classification of the external auditory canal for transcanal endoscopic ear surgery. Eur Ann Otorhinolaryngol Head Neck Dis 2019; 136:247-250. [DOI: 10.1016/j.anorl.2019.03.005] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
9
|
Barrera R, Amador M, Acevedo V, Beltran M, Muñoz JL. A comparison of mosquito densities, weather and infection rates of Aedes aegypti during the first epidemics of Chikungunya (2014) and Zika (2016) in areas with and without vector control in Puerto Rico. Med Vet Entomol 2019; 33:68-77. [PMID: 30225842 PMCID: PMC6378603 DOI: 10.1111/mve.12338] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/30/2018] [Revised: 05/25/2018] [Accepted: 07/26/2018] [Indexed: 05/25/2023]
Abstract
In Puerto Rico, the first records of the transmission of Chikungunya (CHIKV) and Zika (ZIKV) viruses were confirmed in May 2014 and December 2015, respectively. Transmission of CHIKV peaked in September 2014, whereas that of ZIKV peaked in August 2016. The emergence of these mosquito-transmitted arboviruses in the context of a lack of human population immunity allowed observations of whether the outbreaks were associated with Aedes aegypti (Diptera: Culicidae) densities and weather. Mosquito density was monitored weekly in four communities using sentinel autocidal gravid ovitraps (AGO traps) during 2016 in order to provide data to be compared with the findings of a previous study carried out during the 2014 CHIKV epidemic. Findings in two communities protected against Ae. aegypti using mass AGO trapping (three traps per house in most houses) were compared with those in two nearby communities without vector control. Mosquito pools were collected to detect viral RNA of ZIKV, CHIKV and dengue virus. In areas without vector control, mosquito densities and rates of ZIKV detection in 2016 were significantly higher, similarly to those observed for CHIKV in 2014. The density of Ae. aegypti in treated sites was less than two females/trap/week, which is similar to the putative adult female threshold for CHIKV transmission. No significant differences in mosquito density or infection rates with ZIKV and CHIKV at the same sites between years were observed. Although 2016 was significantly wetter, mosquito densities were similar.
Collapse
Affiliation(s)
- R. Barrera
- Entomology and Ecology Team, Dengue BranchCenters for Disease Control and PreventionSan JuanPuerto Rico
| | - M. Amador
- Entomology and Ecology Team, Dengue BranchCenters for Disease Control and PreventionSan JuanPuerto Rico
| | - V. Acevedo
- Entomology and Ecology Team, Dengue BranchCenters for Disease Control and PreventionSan JuanPuerto Rico
| | - M. Beltran
- Molecular Diagnostic Laboratory, Dengue BranchCenters for Disease Control and PreventionSan JuanPuerto Rico
| | - J. L. Muñoz
- Molecular Diagnostic Laboratory, Dengue BranchCenters for Disease Control and PreventionSan JuanPuerto Rico
| |
Collapse
|
10
|
Sartelli M, Abu-Zidan FM, Labricciosa FM, Kluger Y, Coccolini F, Ansaloni L, Leppäniemi A, Kirkpatrick AW, Tolonen M, Tranà C, Regimbeau JM, Hardcastle T, Koshy RM, Abbas A, Aday U, Adesunkanmi ARK, Ajibade A, Akhmeteli L, Akın E, Akkapulu N, Alotaibi A, Altintoprak F, Anyfantakis D, Atanasov B, Augustin G, Azevedo C, Bala M, Balalis D, Baraket O, Baral S, Barkai O, Beltran M, Bini R, Bouliaris K, Caballero AB, Calu V, Catani M, Ceresoli M, Charalampakis V, Jusoh AC, Chiarugi M, Cillara N, Cuesta RC, Cobuccio L, Cocorullo G, Colak E, Conti L, Cui Y, De Simone B, Delibegovic S, Demetrashvili Z, Demetriades D, Dimova A, Dogjani A, Enani M, Farina F, Ferrara F, Foghetti D, Fontana T, Fraga GP, Gachabayov M, Gérard G, Ghnnam W, Maurel TG, Gkiokas G, Gomes CA, Guner A, Gupta S, Hecker A, Hirano ES, Hodonou A, Hutan M, Ilaschuk I, Ioannidis O, Isik A, Ivakhov G, Jain S, Jokubauskas M, Karamarkovic A, Kaushik R, Kenig J, Khokha V, Khokha D, Kim JI, Kong V, Korkolis D, Kruger VF, Kshirsagar A, Simões RL, Lanaia A, Lasithiotakis K, Leão P, Arellano ML, Listle H, Litvin A, Lizarazu Pérez A, Lopez-Tomassetti Fernandez E, Lostoridis E, Luppi D, Machain V GM, Major P, Manatakis D, Reitz MM, Marinis A, Marrelli D, Martínez-Pérez A, Marwah S, McFarlane M, Mesic M, Mesina C, Michalopoulos N, Misiakos E, Moreira FG, Mouaqit O, Muhtaroglu A, Naidoo N, Negoi I, Nikitina Z, Nikolopoulos I, Nita GE, Occhionorelli S, Olaoye I, Ordoñez CA, Ozkan Z, Pal A, Palini GM, Papageorgiou K, Papagoras D, Pata F, Pędziwiatr M, Pereira J, Pereira Junior GA, Perrone G, Pintar T, Pisarska M, Plehutsa O, Podda M, Poillucci G, Quiodettis M, Rahim T, Rios-Cruz D, Rodrigues G, Rozov D, Sakakushev B, Sall I, Sazhin A, Semião M, Sharda T, Shelat V, Sinibaldi G, Skicko D, Skrovina M, Stamatiou D, Stella M, Strzałka M, Sydorchuk R, Teixeira Gonsaga RA, Tochie JN, Tomadze G, Ugoletti L, Ulrych J, Ümarik T, Uzunoglu MY, Vasilescu A, Vaz O, Vereczkei A, Vlad N, Walędziak M, Yahya AI, Yalkin O, Yilmaz TU, Ünal AE, Yuan KC, Zachariah SK, Žilinskas J, Zizzo M, Pattonieri V, Baiocchi GL, Catena F. Physiological parameters for Prognosis in Abdominal Sepsis (PIPAS) Study: a WSES observational study. World J Emerg Surg 2019; 14:34. [PMID: 31341511 PMCID: PMC6631509 DOI: 10.1186/s13017-019-0253-2] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2019] [Accepted: 07/03/2019] [Indexed: 02/08/2023] Open
Abstract
BACKGROUND Timing and adequacy of peritoneal source control are the most important pillars in the management of patients with acute peritonitis. Therefore, early prognostic evaluation of acute peritonitis is paramount to assess the severity and establish a prompt and appropriate treatment. The objectives of this study were to identify clinical and laboratory predictors for in-hospital mortality in patients with acute peritonitis and to develop a warning score system, based on easily recognizable and assessable variables, globally accepted. METHODS This worldwide multicentre observational study included 153 surgical departments across 56 countries over a 4-month study period between February 1, 2018, and May 31, 2018. RESULTS A total of 3137 patients were included, with 1815 (57.9%) men and 1322 (42.1%) women, with a median age of 47 years (interquartile range [IQR] 28-66). The overall in-hospital mortality rate was 8.9%, with a median length of stay of 6 days (IQR 4-10). Using multivariable logistic regression, independent variables associated with in-hospital mortality were identified: age > 80 years, malignancy, severe cardiovascular disease, severe chronic kidney disease, respiratory rate ≥ 22 breaths/min, systolic blood pressure < 100 mmHg, AVPU responsiveness scale (voice and unresponsive), blood oxygen saturation level (SpO2) < 90% in air, platelet count < 50,000 cells/mm3, and lactate > 4 mmol/l. These variables were used to create the PIPAS Severity Score, a bedside early warning score for patients with acute peritonitis. The overall mortality was 2.9% for patients who had scores of 0-1, 22.7% for those who had scores of 2-3, 46.8% for those who had scores of 4-5, and 86.7% for those who have scores of 7-8. CONCLUSIONS The simple PIPAS Severity Score can be used on a global level and can help clinicians to identify patients at high risk for treatment failure and mortality.
Collapse
Affiliation(s)
| | - Fikri M. Abu-Zidan
- 0000 0001 2193 6666grid.43519.3aDepartment of Surgery, College of Medicine and Health Sciences, UAE University, Al-Ain, United Arab Emirates
| | | | - Yoram Kluger
- 0000 0000 9950 8111grid.413731.3Department of General Surgery, Rambam Health Care Campus, Haifa, Israel
| | - Federico Coccolini
- 0000 0004 1758 8744grid.414682.dDepartment of Emergency Surgery, Bufalini Hospital, Cesena, Italy
| | - Luca Ansaloni
- 0000 0004 1758 8744grid.414682.dDepartment of Emergency Surgery, Bufalini Hospital, Cesena, Italy
| | - Ari Leppäniemi
- 0000 0004 0410 2071grid.7737.4Abdominal Center, Department of Abdominal Surgery, Helsinki University Hospital Meilahti and University of Helsinki, Helsinki, Finland
| | - Andrew W. Kirkpatrick
- 0000 0004 0469 2139grid.414959.4General, Acute Care, Abdominal Wall Reconstruction, and Trauma Surgery, Foothills Medical Centre, Calgary, AB Canada
| | - Matti Tolonen
- 0000 0004 0410 2071grid.7737.4Abdominal Center, Department of Abdominal Surgery, Helsinki University Hospital Meilahti and University of Helsinki, Helsinki, Finland
| | - Cristian Tranà
- Department of Surgery, Macerata Hospital, Macerata, Italy
| | - Jean-Marc Regimbeau
- 0000 0004 0593 702Xgrid.134996.0Department of Digestive Surgery and SSPC Research Unit, CHU Amiens-Picardie, Amiens, France
| | - Timothy Hardcastle
- 0000 0001 0723 4123grid.16463.36Department of Trauma ICU, IALCH, University of KwaZulu-Natal, Durban, South Africa
| | - Renol M. Koshy
- 0000 0004 0400 5079grid.412570.5Department of General Surgery, University Hospital of Coventry & Warwickshire, Coventry, UK
| | - Ashraf Abbas
- 0000000103426662grid.10251.37Department of Surgery, Mansoura University and Emergency Hospital, Mansoura, Egypt
| | - Ulaş Aday
- Department of Gastrointestinal Surgery, University of Health Sciences, Elazig Training and Research Hospital, Elazig, Turkey
| | - A. R. K. Adesunkanmi
- 0000 0001 2183 9444grid.10824.3fDepartment of Surgery, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria
| | - Adesina Ajibade
- 0000 0001 0583 749Xgrid.411274.5Department of Surgery, LAUTECH Teaching Hospital, Osogbo, Nigeria
| | - Lali Akhmeteli
- 0000 0004 0428 8304grid.412274.6Department of Surgery, TSMU First University Clinic, Tbilisi, Georgia
| | - Emrah Akın
- 0000 0001 0682 3030grid.49746.38Department of General Surgery, Sakarya University Research and Educational Hospital, Sakarya, Turkey
| | - Nezih Akkapulu
- 0000 0004 0642 1084grid.411920.fDepartment of General Surgery, Hacettepe University Hospital, Ankara, Turkey
| | - Alhenouf Alotaibi
- 0000 0004 0593 1832grid.415277.2Department of Surgical Oncology, King Fahad Medical City, Riyadh, Saudi Arabia
| | - Fatih Altintoprak
- Department of General Surgery, Istinye University Faculty of Medicine, Istanbul, Turkey
| | | | - Boyko Atanasov
- 0000 0001 0726 0380grid.35371.33Surgical Department, UMHAT “Eurohospital”, Medical University, Plovdiv, Bulgaria
| | - Goran Augustin
- 0000 0004 0397 9648grid.412688.1Department of Surgery, University Hospital Centre Zagreb, Zagreb, Croatia
| | - Constança Azevedo
- Cirurgia Geral, Centro Hospitalar Universitário da Cova da Beira, Covilhã, Portugal
| | - Miklosh Bala
- 0000 0001 2221 2926grid.17788.31Department of General Surgery, Hadassah Medical Center, Jerusalem, Israel
| | - Dimitrios Balalis
- Department of Surgery, Saint Savvas Anticancer Hospital, Athens, Greece
| | | | - Suman Baral
- Department of Surgery, Lumbini Medical College and Teaching Hospital Ltd., Tansen, Palpa Nepal
| | - Or Barkai
- 0000 0000 9950 8111grid.413731.3Department of General Surgery, Rambam Health Care Campus, Haifa, Israel
| | - Marcelo Beltran
- Department of Surgery, Hospital San Juan de Dios de La Serena, La Serena, Chile
| | - Roberto Bini
- Emergency and General Surgery, SG Bosco, Torino, Italy
| | | | - Ana B. Caballero
- 0000 0004 0465 2778grid.461067.2General Surgery, Hospital Santo Tomas, Panama, Panama
| | - Valentin Calu
- Department of Surgery, Elias Emergency Hospital, Bucharest, Romania
| | - Marco Catani
- grid.417007.5Dipartimento Emergenza e Accettazione, Policlinico Umberto I, Roma, Italy
| | - Marco Ceresoli
- 0000 0004 1756 8604grid.415025.7Department of General and Emergency Surgery, ASST Monza - Ospedale San Gerardo, Monza, Italy
| | - Vasileios Charalampakis
- 0000 0004 0478 4463grid.440196.eGeneral Surgery, South Warwickshire NHS Foundation Trust, Warwick, UK
| | - Asri Che Jusoh
- Department of General Surgery, Kuala Krai Hospital, Kuala Krai, Malaysia
| | - Massimo Chiarugi
- 0000 0004 1756 8209grid.144189.1U.O. Chirurgia d’Urgenza Universitaria, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy
| | - Nicola Cillara
- grid.459832.1U.O.C. Chirurgia Generale, PO Santissima Trinità, Cagliari, Italia
| | - Raquel Cobos Cuesta
- 0000 0004 1771 208Xgrid.418878.aUGC Cirugía General, Complejo Hospitalario de Jaén, Jaén, Spain
| | - Luigi Cobuccio
- 0000 0004 1756 8209grid.144189.1U.O. Chirurgia d’Urgenza Universitaria, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy
| | - Gianfranco Cocorullo
- Department of General and Emergency Surgery, Azienda Ospedaliera Policlinico Universitario Palermo “Paolo Giaccone”, Palermo, Italy
| | - Elif Colak
- General Surgery, University of Health Sciences, Samsun Training and Research Hospital, Samsun, Turkey
| | - Luigi Conti
- Department of Surgery, G. Da Saliceto Hospital, Piacenza, Italy
| | - Yunfeng Cui
- grid.417036.7Department of Surgery, Tianjin Nankai Hospital, Tianjin, China
| | - Belinda De Simone
- Chirurgie Viscerale et d’Urgence, Centre Hospitalier Regional de Perpignan, Perpignan, France
| | - Samir Delibegovic
- 0000 0001 0682 9061grid.412410.2Department of Surgery, University Clinical Center Tuzla, Tuzla, Bosnia and Herzegovina
| | - Zaza Demetrashvili
- Department of Surgery, Kipshidze Central University Hospital, Tbilisi, Georgia
| | - Demetrios Demetriades
- 0000 0001 0084 1895grid.411409.9Division of Trauma and Acute Care Surgery, LAC+USC Medical Center, Los Angeles, USA
| | - Ana Dimova
- 0000 0004 0397 9648grid.412688.1Department of Surgery, University Hospital Centre Zagreb, Zagreb, Croatia
| | - Agron Dogjani
- Department of General Surgery, University Hospital of Trauma, Tirana, Albania
| | - Mushira Enani
- 0000 0004 0593 1832grid.415277.2Department of Infectious Diseases, King Fahad Medical City, Riyadh, Saudi Arabia
| | - Federica Farina
- 0000 0004 0625 0318grid.459640.aChirurgia Generale, Ospedale Versilia, La Spezia, Italy
| | - Francesco Ferrara
- grid.414126.4Department of Surgery, San Carlo Borromeo Hospital, Milan, Italy
| | - Domitilla Foghetti
- grid.415103.2Department of General Surgery, San Salvatore, Pesaro, Italy
| | - Tommaso Fontana
- Department of General and Emergency Surgery, Azienda Ospedaliera Policlinico Universitario Palermo “Paolo Giaccone”, Palermo, Italy
| | - Gustavo P. Fraga
- 0000 0001 0723 2494grid.411087.bDivision of Trauma Surgery, Hospital de Clinicas, University of Campinas, Campinas, Brazil
| | - Mahir Gachabayov
- Department of Abdominal Surgery, Vladimir City Clinical Hospital of Emergency Medicine, Vladimir, Russia
| | - Grelpois Gérard
- 0000 0004 0593 702Xgrid.134996.0Department of Surgery, University hospital, Amiens, France
| | - Wagih Ghnnam
- grid.469958.fDepartment of General Surgery, Mansoura University Hospital, Mansoura, Egypt
| | - Teresa Giménez Maurel
- 0000 0000 9854 2756grid.411106.3Department of General Surgery, Miguel Servet, Zaragoza, Spain
| | - Georgios Gkiokas
- 0000 0001 2155 0800grid.5216.02nd Department of Surgery, Aretaieion University Hospital, National and Kapodistrian University of Athens, Athens, Greece
| | - Carlos A. Gomes
- Department of Surgery, Hospital Universitário Terezinha de Jesus, Faculdade de Ciências Médicas e da Saúde de Juiz de Fora (SUPREMA), Juiz de Fora, Brazil
| | - Ali Guner
- 0000 0001 2186 0630grid.31564.35Department of General Surgery, Karadeniz Technical University, Trabzon, Turkey
| | - Sanjay Gupta
- 0000 0004 1767 2831grid.413220.6Department of General Surgery, Government Medical College and Hospital, Chandigarh, India
| | - Andreas Hecker
- 0000 0000 8584 9230grid.411067.5Department of General and Thoracic Surgery, University Hospital of Giessen, Giessen, Germany
| | - Elcio S. Hirano
- 0000 0001 0723 2494grid.411087.bDivision of Trauma Surgery, Hospital de Clinicas, University of Campinas, Campinas, Brazil
| | - Adrien Hodonou
- Department of General Surgery, University and Regional Hospital Center of Borgou, Parakou, Republic of Benin
| | - Martin Hutan
- Chirurgische Abteilung, Landesklinikum Hainburg, Hainburg an der Donau, Austria
| | - Igor Ilaschuk
- Intensive Care Unit, Chernivtsi City Emergency Hospital, Chernivtsi, Ukraine
| | - Orestis Ioannidis
- 0000000109457005grid.4793.94th Surgical Department, Medical School, Aristotle University of Thessaloniki, General Hospital “G. Papanikolaou”, Thessaloniki, Greece
| | - Arda Isik
- 0000 0001 1498 7262grid.412176.7Department of General Surgery, Erzincan University Hospital, Erzincan, Turkey
| | - Georgy Ivakhov
- 0000 0000 9559 0613grid.78028.35Department of Faculty Surgery #1, Pirogov Russian National Research Medical University, Moscow, Russia
| | - Sumita Jain
- grid.416065.0Department of Surgery, SMS Hospital, Jaipur, India
| | - Mantas Jokubauskas
- 0000 0004 0575 8750grid.48349.32Department of Surgery, Hospital of Lithuanian University of Health Sciences Kaunas Clinics, Kaunas, Lithuania
| | - Aleksandar Karamarkovic
- Faculty of Medicine University of Belgrade Clinic for Surgery, University Clinical Center “Zvezdara”, Belgrade, Serbia
| | - Robin Kaushik
- 0000 0004 1767 2831grid.413220.6Department of General Surgery, Government Medical College and Hospital, Chandigarh, India
| | - Jakub Kenig
- 0000 0001 2162 9631grid.5522.0Department of General, Oncologic and Geriatric Surgery, Jagiellonian University Collegium Medicum, Kraków, Poland
| | - Vladimir Khokha
- Department of Emergency Surgery, City Hospital, Mozyr, Belarus
| | - Denis Khokha
- Department of Vascular Surgery, City Hospital, Mozyr, Belarus
| | - Jae Il Kim
- 0000 0004 0371 8173grid.411633.2Department of Surgery, Inje University Ilsan Paik Hospital, Goyang, Republic of Korea
| | - Victor Kong
- 0000 0004 0576 7753grid.414386.cTrauma and Acute Care Surgery, Edendale Hospital, Pietermaritzburg, South Africa
| | - Dimitris Korkolis
- Department of Surgery, Saint Savvas Anticancer Hospital, Athens, Greece
| | - Vitor F. Kruger
- 0000 0001 0723 2494grid.411087.bDivision of Trauma Surgery, Hospital de Clinicas, University of Campinas, Campinas, Brazil
| | - Ashok Kshirsagar
- Department of Surgery, Krishna Hospital and Medical Research University Karad, Karad, India
| | - Romeo Lages Simões
- Departament of General Surgery, Hospital Municipal de Governador Valadares, Vale do Rio Doce University, Governador Valadares, Brazil
| | - Andrea Lanaia
- Chirurgia d’Urgenza, Arcispedale Santa Maria Nuova IRCCS, Reggio Emilia, Italy
| | | | - Pedro Leão
- 0000 0001 2159 175Xgrid.10328.38Cirurgia Geral, Hospital de Braga, Life and Health Sciences Research Institute, ICVS/3Bs, Universidade do Minho, Braga, Portugal
| | - Miguel León Arellano
- grid.419651.eGeneral and Digestive Surgery, Hospital Fundación Jimenez Diaz, Madrid, Spain
| | - Holger Listle
- 0000 0000 9116 8976grid.412469.cGeneral, Visceral, Thoracic and Vascular Surgery, University Hospital Greifswald, Greifswald, Germany
| | - Andrey Litvin
- 0000 0001 1018 9204grid.410686.dDepartment of Surgical Disciplines, Regional Clinical Hospital, Immanuel Kant Baltic Federal University, Kaliningrad, Russia
| | - Aintzane Lizarazu Pérez
- grid.414651.3Cirugía general y del aparato digestivo, Hospital Universitario Donostia, Donostia, Spain
| | | | | | - Davide Luppi
- Department of General and Emergency Surgery, ASMN Reggio Emilia, Modena, Italy
| | - Gustavo M. Machain V
- 0000 0001 2289 5077grid.412213.7II Catedra de Clinica Quirúrgica, Hospital de Clinicas, Facultad de Ciencias Médicas, Universidad Nacional de Asunción, Asunción, Paraguay
| | - Piotr Major
- 0000 0001 2162 9631grid.5522.02nd Department of General Surgery, Jagiellonian University Medical College, Kraków, Poland
| | - Dimitrios Manatakis
- 0000 0004 0638 8093grid.414025.6Department of Surgery, Athens Naval and Veterans Hospital, Athens, Greece
| | - Marianne Marchini Reitz
- 0000 0001 0084 1895grid.411409.9Division of Trauma and Acute Care Surgery, LAC+USC Medical Center, Los Angeles, USA
| | - Athanasios Marinis
- grid.417374.2First Department of Surgery, Tzaneio General Hospital, Piraeus, Greece
| | - Daniele Marrelli
- 0000 0004 1757 4641grid.9024.fDepartment of General Surgery and Surgical Oncology, Policlinico Le Scotte, University of Siena, Siena, Italy
| | - Aleix Martínez-Pérez
- 0000 0004 1770 9825grid.411289.7Department of General and Digestive Surgery, Hospital Universitario Doctor Peset, Valencia, Spain
| | - Sanjay Marwah
- 0000 0004 1771 1642grid.412572.7Department of General Surgery, Post-graduate Institute of Medical Sciences, Rohtak, India
| | - Michael McFarlane
- 0000 0004 0500 5353grid.412963.bDepartment of Surgery, Radiology, Anaesthesia and Intensive Care, University Hospital of the West Indies, Kingston, Jamaica
| | - Mirza Mesic
- 0000 0001 0682 9061grid.412410.2Department of Surgery, University Clinical Center Tuzla, Tuzla, Bosnia and Herzegovina
| | - Cristian Mesina
- grid.452359.cSecond Surgical Clinic, Emergency County Hospital of Craiova, Craiova, Romania
| | - Nickos Michalopoulos
- 0000 0004 0576 4544grid.411222.63rd Department of Surgery, Ahepa University Hospital, Thessaloniki, Greece
| | - Evangelos Misiakos
- 0000 0004 0622 4662grid.411449.d3rd Department of Surgery, Attikon University Hospital, Athens, Greece
| | - Felipe Gonçalves Moreira
- Departament of General Surgery, Hospital Municipal de Governador Valadares, Vale do Rio Doce University, Governador Valadares, Brazil
| | - Ouadii Mouaqit
- grid.412817.9Department of Surgery, Hassan II, Fez, Morocco
| | - Ali Muhtaroglu
- 0000 0001 0682 3030grid.49746.38Department of General Surgery, Sakarya University Research and Educational Hospital, Sakarya, Turkey
| | - Noel Naidoo
- Department of Specialist Surgery, Port Shepstone Regional Hospital, Port Shepstone, Republic of South Africa
| | - Ionut Negoi
- General Surgery Department, Emergency Hospital of Bucharest, Bucharest, Romania
| | - Zane Nikitina
- 0000 0004 0375 2558grid.488518.8Toxicology and Sepsis, Riga East University Hospital, Riga, Latvia
| | - Ioannis Nikolopoulos
- grid.439484.6Department of General Surgery, Queen Elizabeth Hospital, London, UK
| | - Gabriela-Elisa Nita
- grid.458453.bChirurgia generale, Sant’Anna (AUSL Reggio Emilia), Castelnovo ne’ Monti, Italy
| | | | - Iyiade Olaoye
- 0000 0000 8878 5287grid.412975.cDepartment of Surgery, University of Ilorin Teaching Hospital, Ilorin, Nigeria
| | - Carlos A. Ordoñez
- 0000 0001 2295 7397grid.8271.cDepartment of Surgery, Fundacion Valle del Lili - Universidad del Valle, Cali, Colombia
| | - Zeynep Ozkan
- Department of General Surgery, University of Health Sciences, Elazig Training and Research Hospital, Elazig, Turkey
| | - Ajay Pal
- 0000 0004 0645 6578grid.411275.4Department of Surgery, King George’s Medical University, Lucknow, India
| | - Gian M. Palini
- grid.414614.2Chirurgia Generale e d’Urgenza, Ospedale Infermi, Rimini, Italy
| | | | - Dimitris Papagoras
- Department of General Surgery, General Hospital of Trikala, Trikala, Greece
| | - Francesco Pata
- Department of Surgery, Sant’Antonio Abate Hospital, Gallarate, Italy
| | - Michał Pędziwiatr
- 0000 0001 1216 0093grid.412700.0Department of General and Emergency Surgery, University Hospital, University Hospital Kraków, Kraków, Poland
| | - Jorge Pereira
- 0000 0004 5914 1131grid.489946.eCirurgia Geral, Centro Hospitalar Tondela-Viseu, Viseu, Portugal
| | | | - Gennaro Perrone
- Chirurgia d’Urgenza – Dipartimento Urgenza/Emergenza, AOU Parma, Parma, Italy
| | - Tadeja Pintar
- 0000 0004 0571 7705grid.29524.38Department of Abdominal Surgery, UMC Ljubljana, Ljubljana, Slovenia
| | - Magdalena Pisarska
- 0000 0001 1216 0093grid.412700.0Department of Endoscopic, Metabolic and Soft Tissue Tumors Surgery, University Hospital, Kraków, Poland
| | - Oleksandr Plehutsa
- Surgery Department, Chernivtsi City Emergency Hospital, Chernivtsi, Ukraine
| | - Mauro Podda
- Department of General, Emergency and Robotic Surgery, San Francesco Hospital, Nuoro, Italy
| | | | - Martha Quiodettis
- 0000 0004 0465 2778grid.461067.2Department of Surgery/Trauma, Hospital Santo Tomás, Panama, Panama
| | - Tuba Rahim
- 0000 0001 0723 4123grid.16463.36Department of Trauma ICU, IALCH, University of KwaZulu-Natal, Durban, South Africa
| | - Daniel Rios-Cruz
- Department of Gastrointestinal Surgery, HGR1 IMSS, Cuernavaca, Mexico
| | - Gabriel Rodrigues
- 0000 0001 0571 5193grid.411639.8Department of General Surgery, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India
| | - Dmytry Rozov
- 0000 0000 9950 8111grid.413731.3Department of General Surgery, Rambam Health Care Campus, Haifa, Israel
| | - Boris Sakakushev
- 0000 0001 1014 775Xgrid.11187.3eFirst Clinic of General Surgery, University Hospital St George/Medical University Plovdiv, Plovdiv, Bulgaria
| | - Ibrahima Sall
- grid.414281.aChirurgie Générale et Viscérale, Hôpital d’instruction des Armées, Hôpital Principal de Dakar, Dakar, Senegal
| | - Alexander Sazhin
- 0000 0000 9559 0613grid.78028.35Department of Faculty Surgery #1, Pirogov Russian National Research Medical University, Moscow, Russia
| | - Miguel Semião
- Cirurgia Geral, Centro Hospitalar Universitário da Cova da Beira, Covilhã, Portugal
| | - Taanya Sharda
- 0000 0004 1767 2831grid.413220.6Department of General Surgery, Government Medical College and Hospital, Chandigarh, India
| | - Vishal Shelat
- grid.240988.fDepartment of General Surgery, Tan Tock Seng Hospital, Singapore, Singapore
| | - Giovanni Sinibaldi
- Department of Surgery, Fatebbenefratelli Hospital, Isola Tiberina, Rome, Italy
| | - Dmitrijs Skicko
- 0000 0004 0375 2558grid.488518.8Department of Surgery (Department No. 10), Riga East Clinical University Hospital “Gaiļezers”, Riga, Latvia
| | - Matej Skrovina
- Department of Surgery, Hospital and Oncological Centre Novy Jicin, Novy Jicin, Czech Republic
| | - Dimitrios Stamatiou
- 0000 0004 0399 7344grid.413964.dGeneral Surgery, Heartlands Hospital, Birmingham, UK
| | - Marco Stella
- grid.414126.4Department of Surgery, San Carlo Borromeo Hospital, Milan, Italy
| | - Marcin Strzałka
- 0000 0001 2162 9631grid.5522.0Department of General Surgery, Polytrauma and Emergency Medicine, University Hospital of the Jagiellonian University Medical College, Kraków, Poland
| | - Ruslan Sydorchuk
- 0000 0004 4906 2392grid.445372.3General Surgery Department, Bukovinian State Medical University, Chernivtsi, Ukraine
| | | | - Joel Noutakdie Tochie
- 0000 0001 2173 8504grid.412661.6Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaounde, Cameroon and Department of Surgery and Anaesthesiology, Yaounde Central Hospital, Yaounde, Cameroon
| | - Gia Tomadze
- 0000 0004 0428 8304grid.412274.6Surgery Department, Tbilisi State Medical University, Tbilisi, Georgia
| | - Lara Ugoletti
- Chirurgia Generale, Ospedale Civile di Guastalla, Reggio Emilia, Italy
| | - Jan Ulrych
- 0000 0000 9100 9940grid.411798.2First Department of Surgery, Department of Abdominal, Thoracic Surgery and Traumatology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
| | - Toomas Ümarik
- 0000 0004 0631 377Xgrid.454953.aUpper Gastrointestinal Tract Surgery Department, North Estonia Medical Centre, Tallinn, Estonia
| | | | - Alin Vasilescu
- First Surgical Unit, “St. Spiridon” University Hospital Iasi, University of Medicine and Pharmacy “Grigore T. Popa”, Iasi, Romania
| | - Osborne Vaz
- 0000 0004 0641 2823grid.419319.7Renal Transplant and General Surgery, Manchester Royal Infirmary, Manchester, UK
| | - Andras Vereczkei
- 0000 0001 0663 9479grid.9679.1Department of Surgery, Clinical Center University of Pecs, Pecs, Hungary
| | - Nutu Vlad
- First Surgical Unit, “St. Spiridon” University Hospital Iasi, University of Medicine and Pharmacy “Grigore T. Popa”, Iasi, Romania
| | - Maciej Walędziak
- 0000 0004 0620 0839grid.415641.3Department of General, Oncological, Metabolic and Thoracic Surgery, Military Institute of Medicine, Warsaw, Poland
| | - Ali I. Yahya
- Department of Surgey, Zliten Teaching Hospital, Zliten, Libya
| | - Omer Yalkin
- 0000000109409118grid.7256.6Department of General Surgery, Ankara University School of Medicine, Ankara, Turkey
| | - Tonguç U. Yilmaz
- grid.488402.2Transplantation Unıt, Acibadem Atakent Hospital, İstanbul, Turkey
| | - Ali Ekrem Ünal
- 0000000109409118grid.7256.6Department of General Surgery, Ankara University School of Medicine, Ankara, Turkey
| | - Kuo-Ching Yuan
- 0000 0004 0639 0994grid.412897.1Department of Surgery, Taipei Medical University Hospital, Taipei, Taiwan
| | - Sanoop K. Zachariah
- 0000 0004 1766 361Xgrid.464618.9Department of Surgery, Mosc Medical College, Kolenchery, Cochin, India
| | - Justas Žilinskas
- Faculty of Medicine University of Belgrade Clinic for Surgery, University Clinical Center “Zvezdara”, Belgrade, Serbia
| | - Maurizio Zizzo
- Surgical Oncology Unit, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy
| | - Vittoria Pattonieri
- grid.411482.aEmergency Surgery Department, Maggiore Parma Hospital, Parma, Italy
| | - Gian Luca Baiocchi
- 0000000417571846grid.7637.5Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
| | - Fausto Catena
- grid.411482.aEmergency Surgery Department, Maggiore Parma Hospital, Parma, Italy
| |
Collapse
|
11
|
Buenaventura J, Beltran M, Sudiacal A. 2.10-P14Setting up a Migrant Health Program: the Philippine experience. Eur J Public Health 2018. [DOI: 10.1093/eurpub/cky048.063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- J Buenaventura
- Migrant Health Unit, Department of Health Philippines, Philippines
| | - M Beltran
- Migrant Health Unit, Department of Health Philippines, Philippines
| | - A Sudiacal
- Migrant Health Unit, Department of Health Philippines, Philippines
| |
Collapse
|
12
|
Sartelli M, Baiocchi GL, Di Saverio S, Ferrara F, Labricciosa FM, Ansaloni L, Coccolini F, Vijayan D, Abbas A, Abongwa HK, Agboola J, Ahmed A, Akhmeteli L, Akkapulu N, Akkucuk S, Altintoprak F, Andreiev AL, Anyfantakis D, Atanasov B, Bala M, Balalis D, Baraket O, Bellanova G, Beltran M, Melo RB, Bini R, Bouliaris K, Brunelli D, Castillo A, Catani M, Che Jusoh A, Chichom-Mefire A, Cocorullo G, Coimbra R, Colak E, Costa S, Das K, Delibegovic S, Demetrashvili Z, Di Carlo I, Kiseleva N, El Zalabany T, Faro M, Ferreira M, Fraga GP, Gachabayov M, Ghnnam WM, Giménez Maurel T, Gkiokas G, Gomes CA, Griffiths E, Guner A, Gupta S, Hecker A, Hirano ES, Hodonou A, Hutan M, Ioannidis O, Isik A, Ivakhov G, Jain S, Jokubauskas M, Karamarkovic A, Kauhanen S, Kaushik R, Kavalakat A, Kenig J, Khokha V, Khor D, Kim D, Kim JI, Kong V, Lasithiotakis K, Leão P, Leon M, Litvin A, Lohsiriwat V, López-Tomassetti Fernandez E, Lostoridis E, Maciel J, Major P, Dimova A, Manatakis D, Marinis A, Martinez-Perez A, Marwah S, McFarlane M, Mesina C, Pędziwiatr M, Michalopoulos N, Misiakos E, Mohamedahmed A, Moldovanu R, Montori G, Mysore Narayana R, Negoi I, Nikolopoulos I, Novelli G, Novikovs V, Olaoye I, Omari A, Ordoñez CA, Ouadii M, Ozkan Z, Pal A, Palini GM, Partecke LI, Pata F, Pędziwiatr M, Pereira Júnior GA, Pintar T, Pisarska M, Ploneda-Valencia CF, Pouggouras K, Prabhu V, Ramakrishnapillai P, Regimbeau JM, Reitz M, Rios-Cruz D, Saar S, Sakakushev B, Seretis C, Sazhin A, Shelat V, Skrovina M, Smirnov D, Spyropoulos C, Strzałka M, Talving P, Teixeira Gonsaga RA, Theobald G, Tomadze G, Torba M, Tranà C, Ulrych J, Uzunoğlu MY, Vasilescu A, Occhionorelli S, Venara A, Vereczkei A, Vettoretto N, Vlad N, Walędziak M, Yilmaz TU, Yuan KC, Yunfeng C, Zilinskas J, Grelpois G, Catena F. Prospective Observational Study on acute Appendicitis Worldwide (POSAW). World J Emerg Surg 2018; 13:19. [PMID: 29686725 PMCID: PMC5902943 DOI: 10.1186/s13017-018-0179-0] [Citation(s) in RCA: 99] [Impact Index Per Article: 16.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2017] [Accepted: 04/04/2018] [Indexed: 02/07/2023] Open
Abstract
BACKGROUND Acute appendicitis (AA) is the most common surgical disease, and appendectomy is the treatment of choice in the majority of cases. A correct diagnosis is key for decreasing the negative appendectomy rate. The management can become difficult in case of complicated appendicitis. The aim of this study is to describe the worldwide clinical and diagnostic work-up and management of AA in surgical departments. METHODS This prospective multicenter observational study was performed in 116 worldwide surgical departments from 44 countries over a 6-month period (April 1, 2016-September 30, 2016). All consecutive patients admitted to surgical departments with a clinical diagnosis of AA were included in the study. RESULTS A total of 4282 patients were enrolled in the POSAW study, 1928 (45%) women and 2354 (55%) men, with a median age of 29 years. Nine hundred and seven (21.2%) patients underwent an abdominal CT scan, 1856 (43.3%) patients an US, and 285 (6.7%) patients both CT scan and US. A total of 4097 (95.7%) patients underwent surgery; 1809 (42.2%) underwent open appendectomy and 2215 (51.7%) had laparoscopic appendectomy. One hundred eighty-five (4.3%) patients were managed conservatively. Major complications occurred in 199 patients (4.6%). The overall mortality rate was 0.28%. CONCLUSIONS The results of the present study confirm the clinical value of imaging techniques and prognostic scores. Appendectomy remains the most effective treatment of acute appendicitis. Mortality rate is low.
Collapse
Affiliation(s)
| | - Gian L. Baiocchi
- 0000000417571846grid.7637.5Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
| | - Salomone Di Saverio
- 0000 0004 1759 7093grid.416290.8Emergency Surgery, Maggiore Hospital, Bologna, Italy
| | - Francesco Ferrara
- grid.414126.4General Surgery and Polytrauma, San Carlo Borromeo Hospital, Milan, Italy
| | - Francesco M. Labricciosa
- Department of Biomedical Sciences and Public Health, Unit of Hygiene, Preventive Medicine and Public Health, UNIVPM, Ancona, Italy
| | - Luca Ansaloni
- 0000 0004 1758 8744grid.414682.dDepartment of Surgery, Bufalini Hospital, Cesena, Italy
| | - Federico Coccolini
- 0000 0004 1758 8744grid.414682.dDepartment of Surgery, Bufalini Hospital, Cesena, Italy
| | - Deepak Vijayan
- 0000 0004 0376 6589grid.412563.7General Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
| | - Ashraf Abbas
- grid.469958.fEmergency Surgery, Mansoura University Hospital, Mansoura, Egypt
| | | | - John Agboola
- Surgery, Kwara State General Hospital, Ilorin, Kwara Nigeria
| | - Adamu Ahmed
- 0000 0004 4688 7583grid.413221.7Surgery, Ahmadu Bello University Teaching Hospital Zaria, Zaria, Nigeria
| | | | - Nezih Akkapulu
- 0000 0001 1457 1144grid.411548.dGeneral Surgery, Baskent Universitesi Adana Eğitim ve Uygulama Hastanesi, Adana, Turkey
| | - Seckin Akkucuk
- 0000 0001 0680 7823grid.14352.31General Surgery, Training and Research Hospital of Mustafa Kemal University, Hatay, Turkey
| | - Fatih Altintoprak
- 0000 0001 0682 3030grid.49746.38General Surgery, Sakarya University School of Medicine, Sakarya, Turkey
| | - Aurelia L. Andreiev
- 0000 0004 0376 6589grid.412563.7General Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
| | | | - Boiko Atanasov
- 0000 0001 0726 0380grid.35371.33Department of General Surgery, Medical University of Plovdiv, UMHAT Eurohospital, Plovdiv, Bulgaria
| | - Miklosh Bala
- 0000 0001 2221 2926grid.17788.31General Surgery, Hadassah Medical Center, Jerusalem, Israel
| | - Dimitrios Balalis
- Surgical Department, Agios Savvas Anticaner Hospital, Athens, Greece
| | - Oussama Baraket
- General Surgery, Hospital Habib Bouguefa de Bizerte, Bizerte, Tunisia
| | | | - Marcelo Beltran
- Surgery, Hospital San Juan de Dios de La Serena, La Serena, Chile
| | - Renato Bessa Melo
- 0000 0000 9375 4688grid.414556.7General Surgery, Centro Hospitalar São João, Porto, Portugal
| | - Roberto Bini
- 0000 0004 1760 7116grid.415044.0General and Emergency Surgery, San Giovanni Bosco Hospital, Turin, Italy
| | | | | | - Adrian Castillo
- 0000 0001 0157 6501grid.239844.0Department of Surgery, Harbor-UCLA Medical Center, Torrance, USA
| | - Marco Catani
- grid.7841.aDEA, La Sapienza Università di Roma, Policlinico Umberto I, Rome, Italy
| | - Asri Che Jusoh
- General Surgery, Kuala Krai Hospital, Kuala Krai, Kelantan Malaysia
| | | | - Gianfranco Cocorullo
- 0000 0004 1756 3088grid.412510.3Emergency Surgery, Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone, Palermo, Italy
| | - Raul Coimbra
- 0000 0001 2107 4242grid.266100.3Trauma/Acute Care Surgery, University of California San Diego, San Diego, USA
| | - Elif Colak
- General Surgery, Samsun Training and Research Hospital, Samsun, Turkey
| | - Silvia Costa
- 0000 0000 8902 4519grid.418336.bSurgery, CHVNG/E, EPE, Vila Nova de Gaia, Portugal
| | - Koray Das
- 0000 0004 0642 7670grid.413791.9General Surgery, Numune Training and Research Hospital, Adana, Turkey
| | - Samir Delibegovic
- 0000 0001 0682 9061grid.412410.2Colorectal Surgery, Clinic for Surgery, University Clinical Center Tuzla, Tuzla, Bosnia and Herzegovina
| | | | - Isidoro Di Carlo
- 0000 0004 0637 437Xgrid.413542.5Surgery, Hamad General Hospital, Doha, Qatar
| | - Nadezda Kiseleva
- 0000 0004 0375 2558grid.488518.8General and Emergency Surgery, Riga East University Hospital “Gailezers”, Riga, Latvia
| | | | - Mario Faro
- 0000 0004 0643 8839grid.412368.aDepartment of General Surgery, Trauma and Emergency Surgery Division, ABC Medical School, Santo Andreì, SP Brazil
| | - Margarida Ferreira
- 0000 0000 8563 4416grid.414708.eGeneral Surgery, Hospital Garcia de Orta, Lisbon, Portugal
| | - Gustavo P. Fraga
- 0000 0001 0723 2494grid.411087.bDivision of Trauma Surgery, Hospital de Clinicas, University of Campinas (Unicamp), Campinas, Brazil
| | - Mahir Gachabayov
- Department of Abdominal Surgery, Vladimir City Clinical Hospital of Emergency Medicine, Vladimir, Russia
| | - Wagih M. Ghnnam
- 0000000103426662grid.10251.37General Surgery Department, Mansoura Faculty of Medicine, Mansoura University, Mansoura, Egypt
| | - Teresa Giménez Maurel
- 0000 0000 9854 2756grid.411106.3Cirugía General y del Aparato Digestivo, Hospital Universitario Miguel Servet, Zaragoza, Spain
| | - Georgios Gkiokas
- 0000 0001 2155 0800grid.5216.0Second Department of Surgery, Aretaieion University Hospital, National and Kapodistrian University of Athens, Athens, Greece
| | - Carlos A. Gomes
- Surgery, Therezinha de Jesus University Hospital, Juiz de Fora, Brazil
| | - Ewen Griffiths
- 0000 0004 0376 6589grid.412563.7Upper GI/General Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
| | - Ali Guner
- 0000 0001 2186 0630grid.31564.35Department of General Surgery, Karadeniz Technical University, Farabi Hospital, Trabzon, Turkey
| | - Sanjay Gupta
- 0000 0004 1767 2831grid.413220.6Surgery, Government Medical College and Hospital, Chandigarh, India
| | - Andreas Hecker
- 0000 0000 8584 9230grid.411067.5Department of General and Thoracic Surgery, University Hospital, Giessen, Germany
| | - Elcio S. Hirano
- 0000 0001 0723 2494grid.411087.bDivision of Trauma Surgery, Hospital de Clinicas, University of Campinas (Unicamp), Campinas, Brazil
| | | | - Martin Hutan
- Surgical Department, Landesklinikum Hainburg, Hainburg An Der Donau, Austria
| | - Orestis Ioannidis
- 0000000109457005grid.4793.94th Surgical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece
- grid.414012.2General Hospital “George Papanikoalou”, Thessaloniki, Greece
| | - Arda Isik
- 0000 0001 1498 7262grid.412176.7General Surgery, Erzincan University Mengucek Gazi Training and Research Hospital, Erzincan, Turkey
| | | | - Sumita Jain
- 0000 0004 1767 3615grid.416077.3Surgery, S M S Medical college, Jaipur, India
| | - Mantas Jokubauskas
- 0000 0004 0575 8750grid.48349.32Department of Surgery, Hospital of Lithuanian University of Health Sciences Kaunas Clinics, Kaunas, Lithuania
| | - Aleksandar Karamarkovic
- 0000 0001 2166 9385grid.7149.bClinic for Emergency Surgery, Faculty of Medicine University of Belgrade, Belgrade, Serbia
| | - Saila Kauhanen
- 0000 0004 0628 215Xgrid.410552.7Division of Digestive Surgery and Urology, Turku University Hospital, Turku, Finland
| | - Robin Kaushik
- 0000 0004 1767 2831grid.413220.6Surgery, Government Medical College and Hospital, Chandigarh, India
| | - Alfie Kavalakat
- 0000 0004 1802 2603grid.464600.0General Surgery, Jubilee Mission Medical College & Research Institute, Thrissur, India
| | - Jakub Kenig
- 0000 0001 2162 9631grid.5522.03rd Department of General Surgery, Jagiellonian University Medical College, Krakow, Poland
| | | | - Desmond Khor
- 0000 0001 0084 1895grid.411409.9Acute Care Surgery, LAC+USC Medical Center, California, USA
| | - Dennis Kim
- 0000 0001 0157 6501grid.239844.0Department of Surgery, Harbor-UCLA Medical Center, Torrance, USA
| | - Jae I. Kim
- 0000 0004 0371 8173grid.411633.2Department of Surgery, Inje University Ilsan Paik Hospital, Goyang, Republic of Korea
| | - Victor Kong
- 0000 0004 0576 7753grid.414386.cDepartment of Surgery, Edendale Hospital, Pietermaritzburg, South Africa
| | | | - Pedro Leão
- General Surgery, Colorectal Unit, Hospital de Braga, Braga, Portugal
| | - Miguel Leon
- grid.419651.eGeneral and Digestive Surgery, Hospital Fundación Jimenez Diaz, Madrid, Spain
| | - Andrey Litvin
- Surgical Disciplines, Regional Clinical Hospital, Kaliningrad, Russia
| | - Varut Lohsiriwat
- grid.416009.aFaculty of Medicine, Department of Surgery, Siriraj Hospital, Mahidol University, Bangkok, Thailand
| | | | | | - James Maciel
- 0000 0001 0157 6501grid.239844.0Department of Surgery, Harbor-UCLA Medical Center, Torrance, USA
| | - Piotr Major
- 0000 0001 2162 9631grid.5522.02nd Department of Surgery, Jagiellonian University Medical College, Krakow, Poland
| | - Ana Dimova
- 0000 0004 0397 9648grid.412688.1Clinic of surgery, Department of Gastrointestinal Surgery, University Hospital Centre Zagreb, Zagreb, Croatia
| | - Dimitrios Manatakis
- grid.414012.2Surgical Department, Konstantopouleio General Hospital, Athens, Greece
| | | | - Aleix Martinez-Perez
- 0000 0004 1770 9825grid.411289.7Department of General and Digestive Surgery, Hospital Universitario Doctor Peset, Valencia, Spain
| | - Sanjay Marwah
- 0000 0004 1771 1642grid.412572.7Department of General Surgery, Post-Graduate Institute of Medical Sciences, Rohtak, India
| | - Michael McFarlane
- 0000 0001 2322 4996grid.12916.3dDepartment of Surgery, Radiology, Anaesthetics and Intensive Care, University of the West Indies, Kingston, Jamaica
- 0000 0004 0500 5353grid.412963.bUniversity Hospital of the West Indies, Kingston, Jamaica
| | - Cristian Mesina
- Department of Surgery Second Surgical Clinic, Emergency Hospital of Craiova, Craiova, Romania
| | - Michał Pędziwiatr
- 0000 0001 1216 0093grid.412700.0Department of General Surgery and Emergency Medicine, University Hospital, Kraków, Poland
| | - Nickos Michalopoulos
- 0000 0004 0576 4544grid.411222.63rd Department of Surgery, Ahepa University Hospital, Thessaloniki, Greece
| | - Evangelos Misiakos
- 0000 0001 2155 0800grid.5216.03rd Department of Surgery, Attikon University Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece
| | | | - Radu Moldovanu
- Department of Visceral, Digestive and Oncologic Surgery, Clinique Sainte Marie, Cambrai, France
| | - Giulia Montori
- 0000 0004 1758 8744grid.414682.dDepartment of Surgery, Bufalini Hospital, Cesena, Italy
| | | | - Ionut Negoi
- General Surgery, Emergency Hospital of Bucharest, Bucharest, Romania
| | | | - Giuseppe Novelli
- grid.414614.2General, Emergency Surgery, Infermi Hospital, Rimini, Italy
| | - Viktors Novikovs
- 0000 0004 0375 2558grid.488518.8General and Emergency Surgery, Riga East University Hospital “Gailezers”, Riga, Latvia
| | - Iyiade Olaoye
- 0000 0000 8878 5287grid.412975.cSurgery, University of Ilorin Teaching Hospital, Ilorin, Nigeria
| | - Abdelkarim Omari
- 0000 0004 0411 3985grid.460946.9General Surgery, King Abdullah University Hospital, Irbid, Jordan
| | - Carlos A. Ordoñez
- grid.477264.4Division of Trauma and Acute Care Surgery, Department of Surgery, Fundación Valle del Lili and Universidad del Valle, Cali, Colombia
| | - Mouaqit Ouadii
- Surgery Departement, Medical School of Fezm, Sidi Mohamed Benabdellah University, Fez, Morocco
| | - Zeynep Ozkan
- General Surgery, Elazig Training and Research Hospital, Elazig, Turkey
| | - Ajay Pal
- 0000 0004 0645 6578grid.411275.4General Surgery, King George’s Medical University, Lucknow, India
| | - Gian M. Palini
- grid.414614.2General, Emergency Surgery, Infermi Hospital, Rimini, Italy
| | | | - Francesco Pata
- Department of General Surgery, Sant’Antonio Abate Hospital, Gallarate, Italy
| | - Michał Pędziwiatr
- 0000 0001 1216 0093grid.412700.0Department of Emergency Surgery and Trauma Centre, University Hospital, Kraków, Poland
| | | | - Tadeja Pintar
- 0000 0004 0571 7705grid.29524.38Abdominal surgery, UMC Ljubljana, Ljubljana, Slovenia
| | - Magdalena Pisarska
- 0000 0001 1216 0093grid.412700.0Department of Endoscopic, Metabolic and Soft Tissue Tumors Surgery, The University Hospital in Krakow, Kraków, Poland
| | - Cesar F. Ploneda-Valencia
- 0000 0001 0432 668Xgrid.459608.6General Surgery, Hospital Civil de Guadalajara “Dr. Juan I. Menchaca”, Guadalajara, Mexico
| | | | - Vinod Prabhu
- 0000 0004 0503 0903grid.411681.bSurgery, Bharati Vidyapeeth Deemed University Medical College & Hospital, Sangli, Maharashtra India
| | | | - Jean-Marc Regimbeau
- 0000 0004 0593 702Xgrid.134996.0Digestive Surgery, CHU Amiens-Picardie, Amiens, France
| | - Marianne Reitz
- General Surgery, Hospital Municipal Dr. Jose de Carvalho Florence, Sao Jose Dos Campos, Brazil
| | - Daniel Rios-Cruz
- General Surgery, Hospital General Regional # 1 I.M.S.S, Cuernavaca, Mexico
| | - Sten Saar
- Acute Care Surgery, North Estonia Medical Center, Tallinn, Estonia
| | - Boris Sakakushev
- General Surgery, University Hospital St George, Plovdiv, Bulgaria
| | - Charalampos Seretis
- 0000 0004 0399 9948grid.416281.8General Surgery, Russells Hall Hospital, Birmingham, UK
| | | | - Vishal Shelat
- grid.240988.fGeneral Surgery, Tan Tock Seng Hospital, Singapore, Singapore
| | - Matej Skrovina
- Surgery, Hospital & Oncological Centre Novy Jicin, Novy Jicin, Czech Republic
| | - Dmitry Smirnov
- General Surgery, Clinical Hospital at Chelyabinsk Station OJSC “Russian Railways”, Chelyabinsk, Russian Federation
| | | | - Marcin Strzałka
- 0000 0001 2162 9631grid.5522.0General Surgery and Polytrauma, University Hospital, Medical College, Jagiellonian University, Kraków, Poland
| | - Peep Talving
- Acute Care Surgery, North Estonia Medical Center, Tallinn, Estonia
| | | | - George Theobald
- 0000 0004 0376 6589grid.412563.7General Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
| | - Gia Tomadze
- 0000 0004 0428 8304grid.412274.6Surgery Department #2, Tbilisi State Medical University, Tbilisi, Georgia
| | - Myftar Torba
- General Surgery, Trauma University Hospital, Tirana, Albania
| | - Cristian Tranà
- Department of Surgery, Macerata Hospital, Macerata, Italy
| | - Jan Ulrych
- 0000 0000 9100 9940grid.411798.21st Department of Surgery—Department of Abdominal Thoracic Surgery and Traumatology, General University Hospital, Prague, Czech Republic
| | - Mustafa Y. Uzunoğlu
- 0000 0001 0680 7823grid.14352.31General Surgery, Training and Research Hospital of Mustafa Kemal University, Hatay, Turkey
| | - Alin Vasilescu
- First Surgical Clinic, St. Spiridon University Hospital, Iasi, Romania
| | | | - Aurélien Venara
- 0000 0004 0472 0283grid.411147.6Digestive and Endocrinal Surgery, University Hospital, Angers, France
| | - Andras Vereczkei
- 0000 0001 0663 9479grid.9679.1Department of Surgery, Medical School University of Pécs, Pécs, Hungary
| | | | - Nutu Vlad
- First Surgical Clinic, St. Spiridon University Hospital, Iasi, Romania
| | - Maciej Walędziak
- 0000 0004 0620 0839grid.415641.3Department of General, Oncological, Metabolic and Thoracic Surgery, Military Institute of Medicine in Warsaw, Warsaw, Poland
| | - Tonguç U. Yilmaz
- 0000 0001 0691 9040grid.411105.0Department of General Surgery, Kocaeli University, Kocaeli, Turkey
| | - Kuo-Ching Yuan
- Trauma and Emergency Surgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan
| | - Cui Yunfeng
- grid.417036.7Department of Surgery, Tianjin Nankai Hospital, Tianjin, China
| | - Justas Zilinskas
- 0000 0004 0575 8750grid.48349.32Department of Surgery, Hospital of Lithuanian University of Health Sciences Kaunas Clinics, Kaunas, Lithuania
| | - Gérard Grelpois
- 0000 0004 0593 702Xgrid.134996.0Digestive Surgery, CHU Amiens-Picardie, Amiens, France
| | - Fausto Catena
- grid.469958.fEmergency Surgery, Mansoura University Hospital, Mansoura, Egypt
| |
Collapse
|
13
|
Ochoa S, López-Carrilero R, Barrigón ML, Pousa E, Barajas A, Lorente-Rovira E, González-Higueras F, Grasa E, Ruiz-Delgado I, Cid J, Birulés I, Esteban-Pinos I, Casañas R, Luengo A, Torres-Hernández P, Corripio I, Montes-Gámez M, Beltran M, De Apraiz A, Domínguez-Sánchez L, Sánchez E, Llacer B, Pélaez T, Bogas JL, Moritz S. Randomized control trial to assess the efficacy of metacognitive training compared with a psycho-educational group in people with a recent-onset psychosis. Psychol Med 2017; 47:1573-1584. [PMID: 28166848 DOI: 10.1017/s0033291716003421] [Citation(s) in RCA: 55] [Impact Index Per Article: 7.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
BACKGROUND Aims were to assess the efficacy of metacognitive training (MCT) in people with a recent onset of psychosis in terms of symptoms as a primary outcome and metacognitive variables as a secondary outcome. METHOD A multicenter, randomized, controlled clinical trial was performed. A total of 126 patients were randomized to an MCT or a psycho-educational intervention with cognitive-behavioral elements. The sample was composed of people with a recent onset of psychosis, recruited from nine public centers in Spain. The treatment consisted of eight weekly sessions for both groups. Patients were assessed at three time-points: baseline, post-treatment, and at 6 months follow-up. The evaluator was blinded to the condition of the patient. Symptoms were assessed with the PANSS and metacognition was assessed with a battery of questionnaires of cognitive biases and social cognition. RESULTS Both MCT and psycho-educational groups had improved symptoms post-treatment and at follow-up, with greater improvements in the MCT group. The MCT group was superior to the psycho-educational group on the Beck Cognitive Insight Scale (BCIS) total (p = 0.026) and self-certainty (p = 0.035) and dependence self-subscale of irrational beliefs, comparing baseline and post-treatment. Moreover, comparing baseline and follow-up, the MCT group was better than the psycho-educational group in self-reflectiveness on the BCIS (p = 0.047), total BCIS (p = 0.045), and intolerance to frustration (p = 0.014). Jumping to Conclusions (JTC) improved more in the MCT group than the psycho-educational group (p = 0.021). Regarding the comparison within each group, Theory of Mind (ToM), Personalizing Bias, and other subscales of irrational beliefs improved in the MCT group but not the psycho-educational group (p < 0.001-0.032). CONCLUSIONS MCT could be an effective psychological intervention for people with recent onset of psychosis in order to improve cognitive insight, JTC, and tolerance to frustration. It seems that MCT could be useful to improve symptoms, ToM, and personalizing bias.
Collapse
Affiliation(s)
- S Ochoa
- Parc Sanitari Sant Joan de Déu,Sant Boi de Llobregat, Barcelona,Spain
| | - R López-Carrilero
- Parc Sanitari Sant Joan de Déu,Sant Boi de Llobregat, Barcelona,Spain
| | - M L Barrigón
- Department of Psychiatry,IIS-Fundación Jiménez Díaz Hospital,Madrid,Spain
| | - E Pousa
- Investigación Biomédica en Red de Salud Mental, CIBERSAM,Madrid,Spain
| | - A Barajas
- Centre d'Higiene Mental Les Corts,Barcelona,Spain
| | - E Lorente-Rovira
- Investigación Biomédica en Red de Salud Mental, CIBERSAM,Madrid,Spain
| | | | - E Grasa
- Investigación Biomédica en Red de Salud Mental, CIBERSAM,Madrid,Spain
| | - I Ruiz-Delgado
- Unidad de Salud Mental Comunitaria Malaga Norte, UGC Salud Mental Carlos Haya,Servicio Andaluz de Salud Málaga,Spain
| | - J Cid
- Mental Health & Addiction Research Group, IdiBGi. Institut d'Assistencia Sanitària,Girona,Spain
| | - I Birulés
- Parc Sanitari Sant Joan de Déu,Sant Boi de Llobregat, Barcelona,Spain
| | - I Esteban-Pinos
- Psychiatry Service, Area de Gestión Sanitaria Sur Granada,Motril,Granada,Spain
| | - R Casañas
- Centre d'Higiene Mental Les Corts,Barcelona,Spain
| | - A Luengo
- Investigación Biomédica en Red de Salud Mental, CIBERSAM,Madrid,Spain
| | | | - I Corripio
- Investigación Biomédica en Red de Salud Mental, CIBERSAM,Madrid,Spain
| | - M Montes-Gámez
- Unidad de Salud Mental Comunitaria Malaga Norte, UGC Salud Mental Carlos Haya,Servicio Andaluz de Salud Málaga,Spain
| | - M Beltran
- Mental Health & Addiction Research Group, IdiBGi. Institut d'Assistencia Sanitària,Girona,Spain
| | - A De Apraiz
- Parc Sanitari Sant Joan de Déu,Sant Boi de Llobregat, Barcelona,Spain
| | - L Domínguez-Sánchez
- Psychiatry Service, Area de Gestión Sanitaria Norte de Málaga,Antequera,Málaga,Spain
| | - E Sánchez
- Centre d'Higiene Mental Les Corts,Barcelona,Spain
| | - B Llacer
- Investigación Biomédica en Red de Salud Mental, CIBERSAM,Madrid,Spain
| | - T Pélaez
- Parc Sanitari Sant Joan de Déu,Sant Boi de Llobregat, Barcelona,Spain
| | - J L Bogas
- Parc Sanitari Sant Joan de Déu,Sant Boi de Llobregat, Barcelona,Spain
| | - S Moritz
- Department of Psychiatry and Psychotherapy,University Medical Center Hamburg,Hamburg,Germany
| |
Collapse
|
14
|
Molla M, Anducas N, Simó M, Seoane A, Ramos M, Cuberas-Borros G, Beltran M, Castell J, Giralt J. A comparative study of the target volume definition in radiotherapy with «Slow CT Scan» vs. 4D PET/CT Scan in early stages non-small cell lung cancer. Rev Esp Med Nucl Imagen Mol 2016; 35:373-378. [PMID: 27106507 DOI: 10.1016/j.remn.2016.02.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2015] [Revised: 01/13/2016] [Accepted: 02/02/2016] [Indexed: 10/21/2022]
Abstract
OBJECTIVES To evaluate the use of 4D PET/CT to quantify tumor respiratory motion compared to the «Slow»-CT (CTs) in the radiotherapy planning process. MATERIAL AND METHODS A total of 25 patients with inoperable early stage non small cell lung cancer (NSCLC) were included in the study. Each patient was imaged with a CTs (4s/slice) and 4D PET/CT. The adequacy of each technique for respiratory motion capture was evaluated using the volume definition for each of the following: Internal target volume (ITV) 4D and ITVslow in relation with the volume defined by the encompassing volume of 4D PET/CT and CTs (ITVtotal). The maximum distance between the edges of the volume defined by each technique to that of the total volume was measured in orthogonal beam's eye view. RESULTS The ITV4D showed less differences in relation with the ITVtotal in both the cranio-caudal and the antero-posterior axis compared to the ITVslow. The maximum differences were 0.36mm in 4D PET/CTand 0.57mm in CTs in the antero-posterior axis. 4D PET/CT resulted in the definition of more accurate (ITV4D/ITVtotal 0.78 vs. ITVs/ITVtotal 0.63), and larger ITVs (19.9 cc vs. 16.3 cc) than those obtained with CTs. CONCLUSION Planning with 4D PET/CT in comparison with CTs, allows incorporating tumor respiratory motion and improving planning radiotherapy of patients in early stages of lung cancer.
Collapse
Affiliation(s)
- M Molla
- Departamento de Oncología Radioteràpica, Hospital Universitario Vall d'Hebron, Barcelona, España.
| | - N Anducas
- Departamento de Física Médica, Hospital Universitario Vall d'Hebron, Barcelona, España
| | - M Simó
- Departamento de Medicina Nuclear, Hospital Universitario Vall d'Hebron, Barcelona, España
| | - A Seoane
- Departamento de Física Médica, Hospital Universitario Vall d'Hebron, Barcelona, España
| | - M Ramos
- Departamento de Oncología Radioteràpica, Hospital Universitario Vall d'Hebron, Barcelona, España
| | - G Cuberas-Borros
- Departamento de Medicina Nuclear, Hospital Universitario Vall d'Hebron, Barcelona, España
| | - M Beltran
- Departamento de Física Médica, Hospital Universitario Vall d'Hebron, Barcelona, España
| | - J Castell
- Departamento de Medicina Nuclear, Hospital Universitario Vall d'Hebron, Barcelona, España
| | - J Giralt
- Departamento de Oncología Radioteràpica, Hospital Universitario Vall d'Hebron, Barcelona, España
| |
Collapse
|
15
|
Molla M, Anducas N, Simó M, Seoane A, Ramos M, Cuberas-Borros G, Beltran M, Castell J, Giralt J. A comparative study of target volume definition in radiotherapy with “Slow CT Scan” vs. 4D PET/CT Scan in early stages of non-small cell lung cancer. Rev Esp Med Nucl Imagen Mol 2016. [DOI: 10.1016/j.remnie.2016.07.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
16
|
Beltran M, Guardeño R. Role of somatostatin analogs(SSA)in combination with targeted agents(TTA)for neuroendocrine tumors(NETs)A systematic review. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw369.27] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
17
|
Pompas-Veganzones N, Sandonis V, Perez-Lanzac A, Beltran M, Beardo P, Juárez A, Vazquez F, Cozar JM, Alvarez-Ossorio JL, Sanchez-Carbayo M. Myopodin methylation is a prognostic biomarker and predicts antiangiogenic response in advanced kidney cancer. Tumour Biol 2016; 37:14301-14310. [PMID: 27592258 DOI: 10.1007/s13277-016-5267-8] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2016] [Accepted: 07/15/2016] [Indexed: 10/21/2022] Open
Abstract
Myopodin is a cytoskeleton protein that shuttles to the nucleus depending on the cellular differentiation and stress. It has shown tumor suppressor functions. Myopodin methylation status was useful for staging bladder and colon tumors and predicting clinical outcome. To our knowledge, myopodin has not been tested in kidney cancer to date. The purpose of this study was to evaluate whether myopodin methylation status could be clinically useful in renal cancer (1) as a prognostic biomarker and 2) as a predictive factor of response to antiangiogenic therapy in patients with metastatic disease. Methylation-specific polymerase chain reactions (MS-PCR) were used to evaluate myopodin methylation in 88 kidney tumors. These belonged to patients with localized disease and no evidence of disease during follow-up (n = 25) (group 1), and 63 patients under antiangiogenic therapy (sunitinib, sorafenib, pazopanib, and temsirolimus), from which group 2 had non-metastatic disease at diagnosis (n = 32), and group 3 showed metastatic disease at diagnosis (n = 31). Univariate and multivariate Cox analyses were utilized to assess outcome and response to antiangiogenic agents taking progression, disease-specific survival, and overall survival as clinical endpoints. Myopodin was methylated in 50 out of the 88 kidney tumors (56.8 %). Among the 88 cases analyzed, 10 of them recurred (11.4 %), 51 progressed (57.9 %), and 40 died of disease (45.4 %). Myopodin methylation status correlated to MSKCC Risk score (p = 0.050) and the presence of distant metastasis (p = 0.039). Taking all patients, an unmethylated myopodin identified patients with shorter progression-free survival, disease-specific survival, and overall survival. Using also in univariate and multivariate models, an unmethylated myopodin predicted response to antiangiogenic therapy (groups 2 and 3) using progression-free survival, disease-specific, and overall survival as clinical endpoints. Myopodin was revealed hypermethylated in kidney cancer. Myopodin methylation status identified which patients showed a more aggressive clinical behavior and predicted antiangiogenic response. These observations support the clinical utility of an unmethylated myopodin as a prognostic and predictive biomarker in kidney cancer.
Collapse
Affiliation(s)
- N Pompas-Veganzones
- Translational Oncology Laboratory, Ikerbasque Research Program, Medicine Department, University of the Basque Country, Vitoria-Gasteiz, Spain
| | - V Sandonis
- Translational Oncology Laboratory, Ikerbasque Research Program, Medicine Department, University of the Basque Country, Vitoria-Gasteiz, Spain
| | | | - M Beltran
- Pathology Department, Hospital Puerta Del Mar, Cadiz, Spain
| | - P Beardo
- Urology Department, Hospital De Jerez, Jerez, Spain
| | - A Juárez
- Urology Department, Hospital De Jerez, Jerez, Spain
| | - F Vazquez
- Urology Department, Hospital Virgen De Las Nieves, Granada, Spain
| | - J M Cozar
- Urology Department, Hospital Virgen De Las Nieves, Granada, Spain
| | | | - Marta Sanchez-Carbayo
- Translational Oncology Laboratory, Ikerbasque Research Program, Medicine Department, University of the Basque Country, Vitoria-Gasteiz, Spain.
| |
Collapse
|
18
|
Molla Armada M, Garcia D, Beltran M, Verges R, Pacheco C, Angles R, Fa X, Saez J, Lobo J, Montiel C, Bordas M, Giralt J. EP-1934: Event reporting and learning in radiotherapy: evaluation over 4 years. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)33185-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
19
|
Beltran M, Salame H, Ricker M, Voordecker P, Lefranc F. [Transdural spinal cord herniation: A rare cause of Brown-Sequard syndrome]. Rev Med Brux 2016; 37:101-103. [PMID: 27487695] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
We report a rare case of thoracic spinal cord herniation due to a defect of the anterior dura mater causing a progressive myelopathy. This case, illustrated by magnetic resonance and surgical imageries, will make the reader aware of this entity and then prevent misdiagnosis.
Collapse
|
20
|
Plummer S, Beltran M, Millar M, Currie R, Wright J. Exploring AOP's and biomarkers of carcinogenesis in rats using laser dissection targeted (LDT) microarray profiling and pathways analysis. Toxicol Lett 2015. [DOI: 10.1016/j.toxlet.2015.08.1098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
21
|
Saez J, Hernandez V, Carrasco P, Beltran M, Calvo J, Escudé L, Quera J, Jornet N. EP-1581: Extending multicenter audits by including complexity of IMRT plans: application to TG119. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)41573-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
22
|
Grande E, Martinez-Trufero J, Arevalo S, Alvarez-Escola C, Beltran M, Jimenez Fonseca P, Alonso-Gordoa T, Dalmau E, Duran M, Gallegos I, Manzano J, Mesia R, Pajares I, Fuentes J, Grau J, Reig Torras O, Trigo J, Pelaez B, Zafon C, Capdevila J. Safety and Efficacy of Vandetanib As Systemic Treatment for Patients with Advanced and Progressive Medullary Thyroid Cancer (Mtc). Ann Oncol 2014. [DOI: 10.1093/annonc/mdu345.30] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
23
|
Maldonado J, Gonzàlez-Juncà A, Beltran M, Martinez Ricarte F, Giralt J, Seoane J. Targeting CD44high/ID1+ Patient Glioma Initiating Cells by TGFβ Receptor I Inhibitor Could Radiosensitize Glioblastoma. Int J Radiat Oncol Biol Phys 2013. [DOI: 10.1016/j.ijrobp.2013.06.1721] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
24
|
Jornet N, Carrasco P, Beltran M, Sáez J, Hernandez V, Calvo J, Escuder L, Quera J. PD-0232: Multicentre validation of IMRT pre-treatment verification: onsite versus external audit. Radiother Oncol 2013. [DOI: 10.1016/s0167-8140(15)32538-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
25
|
Bayley PJ, Isaac L, Kong JY, Adamson MM, Ashford JW, Mahoney LA, Beltran M, Brown-Elhillali A, Held A, Ajayi A, Belcher H, Bond A, Mason H, Lemaster C, Shaw S, Mullin C, Holick E, Saper R, Braun TD, Riley KE, Park CL, Trehern AE, Davis MB, Mastronardi EL, Butzer B, Khalsa SBS, Shorter SM, Reinhardt KM, Cope S, Cheung C, Justice C, Wyman J, Cook-Cottone CP, Daly LA, Haden SC, Hagins M, Danhauer SC, Griffin LP, Avis NE, Sohl SJ, Lawrence J, Jesse MT, Addington EL, Messino MJ, Giguere JK, Lucas SL, Wiliford SK, Shaw E, de Manincor M, Bensoussan A, Smith C, Fahey P, Bourchier S, Desrochers DIM, Viswanathan S, Partharasathy BR, Doherty K, Moye J, Walsh C, Pokaski-Azar J, Gosian J, Chapman J, King K, Sohl S, Danhauer S, Dunbar E, Gabriel MG, Huebner M, Hofmann SG, Khalsa SBS, Gaskins RB, Jennings E, Thind H, Fava JL, Hartman S, Bock BC, Gramann P, Haaz S, Bingham CO, Bartlett SJ, Hagins M, States R, Selfe T, Innes K, Harris AR, Jennings PA, Abenavoli RM, Katz DA, Hudecek KM, Greenberg MT, Jeter PE, Nkodo AF, Haaz S, Dagnelie G, Keosaian JE, Lemaster CM, Chao M, Saper RB, King KD, Gosian J, Doherty K, Walsh C, Pokaski Azar J, Chapman J, Danhauer SC, Moye J, Kinser P, Bourguignon C, Taylor A, Mahoney LA, Bayley PJ, Collery LM, Menzies-Toman D, Nilsson M, Frykman V, Noggle JJ, Braun T, Khalsa SBS, Nosaka M, Okamura H, Fukatu N, Potts A, Weidknecht K, Coulombe S, Davies B, Ryan C, Day D, Reale J, Staples JK, Knoefel J, Herman C, Riley KE, Park CL, Bedesin EY, Stewart VM, Riley KE, Braun TD, Park CL, Pescatello LS, Davis MB, Trehern AE, Mastronardi EL, Rioux J, Rosen RK, Thind H, Gaskins R, Jennings E, Morrow K, Williams D, Bock B, Rousseau D, Jackson E, Schmid AA, Miller KK, Van Puymbroeck M, Debaun EL, Schalk N, Dierks TD, Altenburger P, Damush T, Williams LS, Selman L, Citron T, Howie-Esquivel J, McDermott K, Milic M, Donesky D, Shook A, Ruzic R, Galloway F, Van Puymbroeck M, Miller KK, Schalk N, Schmid AA, Ward LJ, Stebbings S, Sherman K, Cherkin D, Baxter GD, West JI, Duffy N, Liang B. 2013 SYR Accepted Poster Abstracts. Int J Yoga Therap 2013; 23:32-53. [PMID: 24016822] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
|
26
|
Gonzàlez-Juncà A, Maldonado X, Beltran M, Ricarte FM, Rodon J, Seoane J. OC-0069 TGFp RECEPTOR I INHIBITOR RADIOSENSITIZES GLIOBLASTOMA BY TARGETING CD44HIGH/ID1+ GLIOMA INITIATING CELLS. Radiother Oncol 2012. [DOI: 10.1016/s0167-8140(12)70408-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
27
|
|
28
|
Ojeda B, Casado A, Tibau A, Redondo A, Beltran M, Garcia-Martinez E, Santaballa A, Pardo B, Lianes P, Bover I, Garcia-Donas J, Churruca CM, Cueva JF, Sanchez-Heras AB, Gordon-Santiago MM, Arcusa Lanza A, Lopez-Rodriguez A, Caballero C, Ortega-Izquierdo ME, González-Martín A. Bevacizumab alone or with chemotherapy in highly pretreated, relapsed, epithelial ovarian cancer patients. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e15590] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
29
|
Suarez C, Gallardo E, Rodon Ahnert J, Guix M, Bonfill T, Pons F, Beltran M, Moya I, Galtes S, Albanell J, Carles J, Bellmunt J. Phase I study of sunitinib in combination with gemcitabine/capecitabine for the first-line treatment of metastatic or unresectable renal cell carcinoma. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e15095] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
30
|
Albiac MR, Rovira J, Calvo EP, Benavente S, Beltran M, Giralt J. CLINICAL PROSPECTIVE STUDY OF VOLUME AND DOSIMETRIC CHANGES DURING FRACTIONATED RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER. Radiother Oncol 2011. [DOI: 10.1016/s0167-8140(11)70095-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
31
|
Pallí C, Beltran M, Barretina P, Alvarez E, Florensa A, Sala E, Vayreda J, Lluch J. Facing sexual difficulties: A psycho-oncology study with women affected by gynecologic cancer. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.e19563] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
32
|
Peyrade F, Mercier C, Chamorey E, Lallemant B, Alfonsi M, Righini C, Guelfucci B, Beltran M, Zanaret M, Dassonville O. Prognostic index for safety and compliance of docetaxel/ciplatin/5-fluorouracil (TPF) induction followed by radiochemotherapy (RT-CT) in 203 patients (pts) with unresectable squamous cell carcinoma of the head and neck (USCCHN). J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.e16001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
33
|
Cervera JM, Garcia-Carbonero I, Girones R, Beltran M, Calderero V, Gonzalvez ML, Domenech M, Diaz N, Jimenez-Lacave P, Gonzalez A. Clinical experience with oral vinorelbine (NVB) plus prednisone as first- or second-line chemotherapy of metastatic hormone- refractory prostate cancer (HRPC). J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.e16151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e16151 Background: IV NVB plus hydrocortisone (HC) compared with HC alone resulted in improved clinical benefit, progression-free survival (PFS) and PSA response rate in HRPC. The oral formulation of NVB avoids the side effects associated with the IV injection, may reduce administration and toxicity-related costs and is easy to administer. Due to these advantages, single agent oral NVB treatment could be considered as an optimal option for patients (p) with HRPC previously treated with a taxane or as first-line treatment when a taxane is not indicated. We retrospectively evaluated efficacy and toxicity or oral NVB administered as single agent as first or second-line chemotherapy of metastatic HRPC. Methods: Retrospectively data was collected from p with metastatic HRPC treated with oral NVB 80 mg/m2 days 1 and 8, with a prior test of myelosensitivity at 60 mg/m2 for the first cycle, plus prednisone 10 mg/day. Patients had received a taxane as first-line treatment or had a documented contraindication to receiving docetaxel. 1 cycle was equivalent to a 3-week period. Results: Data on 55 p treated in 11 Spanish centres were included for assessment. Median age was 72.5 years (range 54–86). ECOG PS 0, 17%; 1, 66%; 2, 17%. Median PSA 75 ng/mL. Prior taxane chemotherapy, 87%. Median number of cycles was 4 (range 1–6). 53.8% of p could escalate oral NVB to 80 mg/m2. 221 cycles were performed, 4.1% were delayed and 3.2% had a dose reduction. Grade 3–4 events were infrequent and mainly haematological: neutropenia (5.5% of p), anemia (3.6%), pain (3.6%), infection (1.8%), asthenia (1.8%), respiratory (1.8%). No febrile neutropenia was reported. 49 p were evaluable for PSA response rate; complete plus partial response was observed in 20.4% (95% CI: 10.2% - 34.3%) and PSA stable was reported in 40.8%. 29 p were evaluable for measurable disease; among them, 20.7% presented partial response and 44.8% stable disease. Median follow-up was 4.3 months. Survival status: 49 p (89.1%) are alive and 6 p (10.9%) died. Conclusions: Oral NVB is a safe and active regimen in previous chemotherapy treated HRPC. For those p who can not receive a taxane as first-line therapy, oral NVB can also be considered as an effective first-line treatment. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- J. M. Cervera
- Hospital General de Elda, Elda, Spain; Hospital Virgen de la Salud, Toledo, Spain; Hospital Lluis Alcanys, Xativa, Spain; ICO, Hospital Dr. Josep Trueta, Girona, Spain; Hospital Universitario Miguel Servet, Zaragoza, Spain; Hospital Universitario Virgen de la Arrixaca, Murcia, Spain; Fundacio Althaia, Manresa, Spain; Hospital Universitario San Juan, San Juan de Alicante, Spain; Hospital Universitario Central de Asturias, Oviedo, Spain; Hospital Universitario Son Dureta, Palma de Mallorca, Spain
| | - I. Garcia-Carbonero
- Hospital General de Elda, Elda, Spain; Hospital Virgen de la Salud, Toledo, Spain; Hospital Lluis Alcanys, Xativa, Spain; ICO, Hospital Dr. Josep Trueta, Girona, Spain; Hospital Universitario Miguel Servet, Zaragoza, Spain; Hospital Universitario Virgen de la Arrixaca, Murcia, Spain; Fundacio Althaia, Manresa, Spain; Hospital Universitario San Juan, San Juan de Alicante, Spain; Hospital Universitario Central de Asturias, Oviedo, Spain; Hospital Universitario Son Dureta, Palma de Mallorca, Spain
| | - R. Girones
- Hospital General de Elda, Elda, Spain; Hospital Virgen de la Salud, Toledo, Spain; Hospital Lluis Alcanys, Xativa, Spain; ICO, Hospital Dr. Josep Trueta, Girona, Spain; Hospital Universitario Miguel Servet, Zaragoza, Spain; Hospital Universitario Virgen de la Arrixaca, Murcia, Spain; Fundacio Althaia, Manresa, Spain; Hospital Universitario San Juan, San Juan de Alicante, Spain; Hospital Universitario Central de Asturias, Oviedo, Spain; Hospital Universitario Son Dureta, Palma de Mallorca, Spain
| | - M. Beltran
- Hospital General de Elda, Elda, Spain; Hospital Virgen de la Salud, Toledo, Spain; Hospital Lluis Alcanys, Xativa, Spain; ICO, Hospital Dr. Josep Trueta, Girona, Spain; Hospital Universitario Miguel Servet, Zaragoza, Spain; Hospital Universitario Virgen de la Arrixaca, Murcia, Spain; Fundacio Althaia, Manresa, Spain; Hospital Universitario San Juan, San Juan de Alicante, Spain; Hospital Universitario Central de Asturias, Oviedo, Spain; Hospital Universitario Son Dureta, Palma de Mallorca, Spain
| | - V. Calderero
- Hospital General de Elda, Elda, Spain; Hospital Virgen de la Salud, Toledo, Spain; Hospital Lluis Alcanys, Xativa, Spain; ICO, Hospital Dr. Josep Trueta, Girona, Spain; Hospital Universitario Miguel Servet, Zaragoza, Spain; Hospital Universitario Virgen de la Arrixaca, Murcia, Spain; Fundacio Althaia, Manresa, Spain; Hospital Universitario San Juan, San Juan de Alicante, Spain; Hospital Universitario Central de Asturias, Oviedo, Spain; Hospital Universitario Son Dureta, Palma de Mallorca, Spain
| | - M. L. Gonzalvez
- Hospital General de Elda, Elda, Spain; Hospital Virgen de la Salud, Toledo, Spain; Hospital Lluis Alcanys, Xativa, Spain; ICO, Hospital Dr. Josep Trueta, Girona, Spain; Hospital Universitario Miguel Servet, Zaragoza, Spain; Hospital Universitario Virgen de la Arrixaca, Murcia, Spain; Fundacio Althaia, Manresa, Spain; Hospital Universitario San Juan, San Juan de Alicante, Spain; Hospital Universitario Central de Asturias, Oviedo, Spain; Hospital Universitario Son Dureta, Palma de Mallorca, Spain
| | - M. Domenech
- Hospital General de Elda, Elda, Spain; Hospital Virgen de la Salud, Toledo, Spain; Hospital Lluis Alcanys, Xativa, Spain; ICO, Hospital Dr. Josep Trueta, Girona, Spain; Hospital Universitario Miguel Servet, Zaragoza, Spain; Hospital Universitario Virgen de la Arrixaca, Murcia, Spain; Fundacio Althaia, Manresa, Spain; Hospital Universitario San Juan, San Juan de Alicante, Spain; Hospital Universitario Central de Asturias, Oviedo, Spain; Hospital Universitario Son Dureta, Palma de Mallorca, Spain
| | - N. Diaz
- Hospital General de Elda, Elda, Spain; Hospital Virgen de la Salud, Toledo, Spain; Hospital Lluis Alcanys, Xativa, Spain; ICO, Hospital Dr. Josep Trueta, Girona, Spain; Hospital Universitario Miguel Servet, Zaragoza, Spain; Hospital Universitario Virgen de la Arrixaca, Murcia, Spain; Fundacio Althaia, Manresa, Spain; Hospital Universitario San Juan, San Juan de Alicante, Spain; Hospital Universitario Central de Asturias, Oviedo, Spain; Hospital Universitario Son Dureta, Palma de Mallorca, Spain
| | - P. Jimenez-Lacave
- Hospital General de Elda, Elda, Spain; Hospital Virgen de la Salud, Toledo, Spain; Hospital Lluis Alcanys, Xativa, Spain; ICO, Hospital Dr. Josep Trueta, Girona, Spain; Hospital Universitario Miguel Servet, Zaragoza, Spain; Hospital Universitario Virgen de la Arrixaca, Murcia, Spain; Fundacio Althaia, Manresa, Spain; Hospital Universitario San Juan, San Juan de Alicante, Spain; Hospital Universitario Central de Asturias, Oviedo, Spain; Hospital Universitario Son Dureta, Palma de Mallorca, Spain
| | - A. Gonzalez
- Hospital General de Elda, Elda, Spain; Hospital Virgen de la Salud, Toledo, Spain; Hospital Lluis Alcanys, Xativa, Spain; ICO, Hospital Dr. Josep Trueta, Girona, Spain; Hospital Universitario Miguel Servet, Zaragoza, Spain; Hospital Universitario Virgen de la Arrixaca, Murcia, Spain; Fundacio Althaia, Manresa, Spain; Hospital Universitario San Juan, San Juan de Alicante, Spain; Hospital Universitario Central de Asturias, Oviedo, Spain; Hospital Universitario Son Dureta, Palma de Mallorca, Spain
| |
Collapse
|
34
|
Zala C, Rustad CA, Chan K, Khan NI, Beltran M, Warley E, Ceriotto M, Druyts EF, Hogg RS, Montaner J, Cahn P. Determinants of Treatment Access in a Population-based Cohort of HIV-positive Men and Women Living in Argentina. J Int AIDS Soc 2008; 10:78. [PMID: 19825142 PMCID: PMC2757395 DOI: 10.1186/1758-2652-10-4-78] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
OBJECTIVE To report emerging data on the use of highly active antiretroviral therapy (HAART) in Argentina by assessing patterns of HAART access and late vs early treatment initiation in a population-based cohort of adults infected with HIV type-1. DESIGN The Prospective Study on the Use and Monitoring of Antiretroviral Therapy (PUMA) is a study of 883 HIV-positive individuals enrolled in the Argentinean drug treatment program. Individuals were 16 years of age and older and were recruited from 10 clinics across Argentina. METHODS Sociodemographic and clinical characteristics were examined using contingency tables (Pearson chi-square test and Fisher exact test) for categoric variables and Wilcoxon rank-sum test for continuous variables. To analyze time to initiation of HAART we used Kaplan-Meier methods and Cox regression. RESULTS Patients who initiated HAART were more likely to be older, have an AIDS-defining illness, be an injection drug user (IDU), have a lower median CD4 cell count, have a higher median viral load, and be less likely to be men who have sex with men (MSM). In multivariate analysis, AIDS-defining illness and plasma viral load were significantly associated with time to starting therapy. Patients who received late access were more likely to be diagnosed with AIDS and have higher median plasma viral loads than those receiving early access. CONCLUSION Our results indicate that despite free availability of treatment, monitoring, and care in Argentina, a significant proportion of men and women are accessing HAART late in the course of HIV disease. Further characterization of the HIV-positive population will allow for a more comprehensive evaluation of the impact of HAART within the Argentinean drug treatment program.
Collapse
Affiliation(s)
- Carlos Zala
- Medical Director, Fundacion "Dra, Cecilia Grierson", Buenos Aires, Argentina.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Zala C, Rustad CA, Chan K, Khan NI, Beltran M, Warley E, Ceriotto M, Druyts EF, Hogg RS, Montaner J, Cahn P. Determinants of treatment access in a population-based cohort of HIV-positive men and women living in Argentina. Medscape J Med 2008; 10:78. [PMID: 18504475 PMCID: PMC2390686] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
OBJECTIVE To report emerging data on the use of highly active antiretroviral therapy (HAART) in Argentina by assessing patterns of HAART access and late vs early treatment initiation in a population-based cohort of adults infected with HIV type-1. DESIGN The Prospective Study on the Use and Monitoring of Antiretroviral Therapy (PUMA) is a study of 883 HIV-positive individuals enrolled in the Argentinean drug treatment program. Individuals were 16 years of age and older and were recruited from 10 clinics across Argentina. METHODS Sociodemographic and clinical characteristics were examined using contingency tables (Pearson chi-square test and Fisher exact test) for categoric variables and Wilcoxon rank-sum test for continuous variables. To analyze time to initiation of HAART we used Kaplan-Meier methods and Cox regression. RESULTS Patients who initiated HAART were more likely to be older, have an AIDS-defining illness, be an injection drug user (IDU), have a lower median CD4 cell count, have a higher median viral load, and be less likely to be men who have sex with men (MSM). In multivariate analysis, AIDS-defining illness and plasma viral load were significantly associated with time to starting therapy. Patients who received late access were more likely to be diagnosed with AIDS and have higher median plasma viral loads than those receiving early access. CONCLUSION Our results indicate that despite free availability of treatment, monitoring, and care in Argentina, a significant proportion of men and women are accessing HAART late in the course of HIV disease. Further characterization of the HIV-positive population will allow for a more comprehensive evaluation of the impact of HAART within the Argentinean drug treatment program.
Collapse
Affiliation(s)
- Carlos Zala
- Fundacion Dra. Cecilia Grierson, Buenos Aires, Argentina.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Abstract
BACKGROUND Roux-en-Y gastric bypass is the most frequent bariatric operation. In this operation, the distal bypassed stomach is left in situ. We studied pre-operative clinical, endoscopic and histologic findings in a consecutive group of morbidly obese patients prior to bariatric surgery. METHODS A prospective study was conducted from August 1999 until May 2004, which consisted of 426 patients with morbid obesity. There were 94 men and 332 women, with mean age 39.5 years. In all patients prior to surgery, upper endoscopy was performed and biopsy samples were taken distal to squamo-columnar junction (cardiac biopsies), and in 232 of them also in at the antrum. RESULTS Pathological findings at the esophagus were seen in 55% of the patients, mainly related to reflux esophagitis. Barrett's esophagus was seen in 5.8%. In the stomach, pathological findings were seen in 32% of the patients. Active peptic ulcer was demonstrated in 2.6% of the cases. At the duodenum, pathologic findings were detected in 13.4% of the patients, showing an ulcer in 2.6%. At the stomach, chronic inactive gastritis and atrophic gastritis with intestinal metaplasia were found in 8.6% and 6.5% respectively. Antral adenoma with low-grade dysplasia was found in 1 patient, and 1 carcinoid tumor. H. pylori was present in 53% of the patients, mainly in the antrum. CONCLUSION In candidates for bariatric surgery, upper endoscopy with biopsy samples and determination of H. pylori should be routinely performed. If present, H. pylori should be eradicated. After surgery, if Barrett's esophagus was present, endoscopic surveillance is recommended.
Collapse
Affiliation(s)
- Attila Csendes
- Department of Surgery and Pathology, University Hospital, Santiago, Chile.
| | | | | | | |
Collapse
|
37
|
Ebener S, Khan A, Shademani R, Compernolle L, Beltran M, Lansang M, Lippman M. Knowledge mapping as a technique to support knowledge translation. Bull World Health Organ 2006; 84:636-42. [PMID: 16917651 PMCID: PMC2627443 DOI: 10.2471/blt.06.029736] [Citation(s) in RCA: 45] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2006] [Accepted: 05/26/2006] [Indexed: 11/27/2022] Open
Abstract
This paper explores the possibility of integrating knowledge mapping into a conceptual framework that could serve as a tool for understanding the many complex processes, resources and people involved in a health system, and for identifying potential gaps within knowledge translation processes in order to address them. After defining knowledge mapping, this paper presents various examples of the application of this process in health, before looking at the steps that need to be taken to identify potential gaps, to determine to what extent these gaps affect the knowledge translation process and to establish their cause. This is followed by proposals for interventions aimed at strengthening the overall process. Finally, potential limitations on the application of this framework at the country level are addressed.
Collapse
Affiliation(s)
- S Ebener
- Knowledge Management and Sharing Department, World Health Organization, Geneva, Switzerland.
| | | | | | | | | | | | | |
Collapse
|
38
|
Colomer R, Tusquets I, Calvo L, Dorca J, Adrover E, Sanchez-Rovira P, Rifa J, De La Haba J, Virizuela JA, Beltran M. Liposomal doxorubicin (M) plus gemcitabine (G) as first line treatment in metastatic breast carcinoma: A phase I-II study. J Clin Oncol 2006. [DOI: 10.1200/jco.2006.24.18_suppl.10651] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
10651 Background: We designed a phase I-II trial to determine the combination dose of liposomal doxorubicin (Myocet) plus gemcitabine (Gemzar), and to evaluate the safety and feasibility of the regimen Methods: Patients with histologically confirmed breast cancer, untreated distant metastasis, age >18 years old, left ventricular ejection fraction (LVEF) >50% and adequate bone marrow, renal and hepatic function were included in the study. Patients received up to six cycles of treatment. No G-CSF support was used prophylactically. LVEF was repeated at 3, and 6 months, and every 6 months thereafter. Results: Phase I: After 6 patients, the recommended dose was M (55 mg/m2) D1 and G (900 mg/m2) D1 and 8, administered every 21 days. Phase II: 53 patients have been enrolled; 52 are included in the safety analysis and 42 in the efficacy analysis. The median age of the population was 61 years of age (32–79). ECOG PS was 0 in 55%, 1 in 41%, 2 in 4%. Postmenopausal status in 87%. Main histology was ductal carcinoma (85%). Prior adjuvant anthracyclines had been administered in 19 cases (median dose of doxorubicin: 300 mg/m2, or epirubicin: 425 mg/m2). Metastasic lesions were in liver (25), lung (17), bone (16), and lymph nodes (25). Patients received a median number of 5 cycles (range 1–6). Median relative dose intensity was 83% for M and 75% for G. Grade III-IV hematologic toxicity per administered cycles was: leukopenia (21.9%), neutropenia (31.2%), febrile neutropenia (4 %), and thrombocytopenia (7.4%). Grade III-IV non-hematologic toxicities were stomatitis (4.8%), nausea (1.7%), vomiting (2.2%), asthenia (2.6%) and diarrhea (0.8%). Thirteen of 52 pts (25%) had alopecia grade III-IV. No signs or symptoms of cardiac impairment have been seen. An objective response rate of 62% was obtained (95% CI: 45.6- 76.4%). Two patients had complete response (4.8%), 24 partial response (57.1%), 10 stable disease and 6 progressive disease. The response rate was similar in patients with or without previous adjuvant anthracyclines (68.5% and 61%, respectively). Conclusions: The combination of liposomal doxorubicin plus gemcitabine has high efficacy and low toxicity in advanced breast cancer patients, and may be a valuable option in patients that have received adjuvant anthracyclines. [Table: see text]
Collapse
Affiliation(s)
- R. Colomer
- Institut Catala d’Oncologia, Girona, Spain; Hospital del Mar, Barcelona, Spain; Hospital Juan Canalejo, La Coruña, Spain; Hospital General Alicante, Alicante, Spain; Hospital de Jaen, Jaen, Spain; Hospital Son Dureta, Palma de Mallorca, Spain; Hospital Reina Sofía, Cordoba, Spain; Hospital Virgen Macarena, Sevilla, Spain
| | - I. Tusquets
- Institut Catala d’Oncologia, Girona, Spain; Hospital del Mar, Barcelona, Spain; Hospital Juan Canalejo, La Coruña, Spain; Hospital General Alicante, Alicante, Spain; Hospital de Jaen, Jaen, Spain; Hospital Son Dureta, Palma de Mallorca, Spain; Hospital Reina Sofía, Cordoba, Spain; Hospital Virgen Macarena, Sevilla, Spain
| | - L. Calvo
- Institut Catala d’Oncologia, Girona, Spain; Hospital del Mar, Barcelona, Spain; Hospital Juan Canalejo, La Coruña, Spain; Hospital General Alicante, Alicante, Spain; Hospital de Jaen, Jaen, Spain; Hospital Son Dureta, Palma de Mallorca, Spain; Hospital Reina Sofía, Cordoba, Spain; Hospital Virgen Macarena, Sevilla, Spain
| | - J. Dorca
- Institut Catala d’Oncologia, Girona, Spain; Hospital del Mar, Barcelona, Spain; Hospital Juan Canalejo, La Coruña, Spain; Hospital General Alicante, Alicante, Spain; Hospital de Jaen, Jaen, Spain; Hospital Son Dureta, Palma de Mallorca, Spain; Hospital Reina Sofía, Cordoba, Spain; Hospital Virgen Macarena, Sevilla, Spain
| | - E. Adrover
- Institut Catala d’Oncologia, Girona, Spain; Hospital del Mar, Barcelona, Spain; Hospital Juan Canalejo, La Coruña, Spain; Hospital General Alicante, Alicante, Spain; Hospital de Jaen, Jaen, Spain; Hospital Son Dureta, Palma de Mallorca, Spain; Hospital Reina Sofía, Cordoba, Spain; Hospital Virgen Macarena, Sevilla, Spain
| | - P. Sanchez-Rovira
- Institut Catala d’Oncologia, Girona, Spain; Hospital del Mar, Barcelona, Spain; Hospital Juan Canalejo, La Coruña, Spain; Hospital General Alicante, Alicante, Spain; Hospital de Jaen, Jaen, Spain; Hospital Son Dureta, Palma de Mallorca, Spain; Hospital Reina Sofía, Cordoba, Spain; Hospital Virgen Macarena, Sevilla, Spain
| | - J. Rifa
- Institut Catala d’Oncologia, Girona, Spain; Hospital del Mar, Barcelona, Spain; Hospital Juan Canalejo, La Coruña, Spain; Hospital General Alicante, Alicante, Spain; Hospital de Jaen, Jaen, Spain; Hospital Son Dureta, Palma de Mallorca, Spain; Hospital Reina Sofía, Cordoba, Spain; Hospital Virgen Macarena, Sevilla, Spain
| | - J. De La Haba
- Institut Catala d’Oncologia, Girona, Spain; Hospital del Mar, Barcelona, Spain; Hospital Juan Canalejo, La Coruña, Spain; Hospital General Alicante, Alicante, Spain; Hospital de Jaen, Jaen, Spain; Hospital Son Dureta, Palma de Mallorca, Spain; Hospital Reina Sofía, Cordoba, Spain; Hospital Virgen Macarena, Sevilla, Spain
| | - J. A. Virizuela
- Institut Catala d’Oncologia, Girona, Spain; Hospital del Mar, Barcelona, Spain; Hospital Juan Canalejo, La Coruña, Spain; Hospital General Alicante, Alicante, Spain; Hospital de Jaen, Jaen, Spain; Hospital Son Dureta, Palma de Mallorca, Spain; Hospital Reina Sofía, Cordoba, Spain; Hospital Virgen Macarena, Sevilla, Spain
| | - M. Beltran
- Institut Catala d’Oncologia, Girona, Spain; Hospital del Mar, Barcelona, Spain; Hospital Juan Canalejo, La Coruña, Spain; Hospital General Alicante, Alicante, Spain; Hospital de Jaen, Jaen, Spain; Hospital Son Dureta, Palma de Mallorca, Spain; Hospital Reina Sofía, Cordoba, Spain; Hospital Virgen Macarena, Sevilla, Spain
| |
Collapse
|
39
|
Velazquez C, Beltran M, Ontiveros N, Rascon L, Figueroa DC, Granados AJ, Hernandez-Martinez J, Hernandez J, Astiazaran-Garcia H. Giardia lamblia infection induces different secretory and systemic antibody responses in mice. Parasite Immunol 2005; 27:351-6. [PMID: 16149993 DOI: 10.1111/j.1365-3024.2005.00793.x] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
The adult mouse model of Giardia lamblia infection serves as an excellent animal model to understand the immunological mechanisms involved in the control and clearance of Giardia infection. Little is known about the G. lamblia-specific antigens that stimulate the humoral immune response in this model of giardiasis. We analysed the secretory and systemic antibody responses to G. lamblia during primary and secondary infection in C3H/HeJ adult mice. Faecal IgA and Serum IgG anti-G. lamblia antibodies were observed at week 2 post-infection. Serum IgG responses remained constant over the next several weeks, whereas faecal IgA titres continued to rise from weeks 2-6 post-infection. Western blot analysis revealed that intestinal IgA and serum IgG antibody responses were directed toward several distinct proteins of G. lamblia. Certain proteins appeared to be recognized by both faecal IgA and serum IgG, whereas other antigens were specific for either the secretory or systemic antibody responses. G. lamblia primary and secondary infections were associated with differences in the antibody recognition pattern. The biochemical and immunological characterization of these antigens will help us to better understand the immunobiology of the G. lamblia-host interaction.
Collapse
Affiliation(s)
- C Velazquez
- Department of Chemistry-Biology, University of Sonora, Hermosillo, Sonora, México.
| | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Colomer R, Beltran M, Dorcas J, Cortes-Funes H, Hornedo J, Valentin V, Vargas C, Mendiola C, Ciruelos E. It Is Not Time to Stop Progesterone Receptor Testing in Breast Cancer. J Clin Oncol 2005; 23:3868-9; author reply 3869-70. [PMID: 15923595 DOI: 10.1200/jco.2005.05.203] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
41
|
Csendes A, Rencoret G, Beltran M, Smok G, Henríquez A. [Relationship between gastroesophageal reflux symptoms and 24 h esophageal pH measurement in patients with normal or minimally abnormal upper endoscopies]. Rev Med Chil 2005; 132:19-25. [PMID: 15379048 DOI: 10.4067/s0034-98872004000100003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
BACKGROUND Heartburn and regurgitation are considered highly specific symptoms of gastroesophageal reflux. A considerable number of patients with these symptoms do not have endoscopic signs of esophagitis. AIM To study the relationship between gastroesophageal reflux symptoms and 24 h esophageal pH mesurement in patients with normal or near normal endoscopic findings. PATIENTS AND METHODS One hundred eighty six patients with persistent reflux symptoms and absence of severe endoscopic esophagitis were studied. Pathological studies of esophageal biopsies, manometry and 24 h esophageal pH measurements were performed in all. RESULTS Abnormal acid reflux was found in 131 patients (70%). No differences in the frequency of symptoms, gender or pathologic findings were observed between patients with or without abnormal acid reflux. However, a higher frequency of esophageal erosions and a lower resting pressure of the inferior sphincter of the esophagus was observed in patients with abnormal acid reflux. CONCLUSIONS Thirty percent of patients with heartburn and regurgtitation did not have abnormal acid reflux. Therefore, these symptoms are not specific for gastroesophageal reflux.
Collapse
Affiliation(s)
- Attila Csendes
- Departamento de Cirugía, Hospital Clinico de la Universidad de Chile, Santiago, Chile.
| | | | | | | | | |
Collapse
|
42
|
Beltran M. Demographic Assessment of Pain Relief in the Emergency Department. Acad Emerg Med 2004. [DOI: 10.1197/j.aem.2004.02.417] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
43
|
Colomer R, Viñas G, Beltran M, Izquierdo A, Lluch A, Llombart-Cussac A, Alba E, Munárriz B, Martín M. Validation of the 2001 St Gallen risk categories for node-negative breast cancer using a database from the Spanish Breast Cancer Research Group (GEICAM). J Clin Oncol 2004; 22:961-2. [PMID: 14990656 DOI: 10.1200/jco.2004.99.143] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
44
|
McCauley LA, Beltran M, Phillips J, Lasarev M, Sticker D. The Oregon migrant farmworker community: an evolving model for participatory research. Environ Health Perspect 2001; 109 Suppl 3:449-455. [PMID: 11427395 PMCID: PMC1240564 DOI: 10.1289/ehp.01109s3449] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
Migrant farmworker communities present distinct challenges that require new approaches for community participation in research. In the State of Oregon an agency that advocates for the migrant farmworker community has collaborated successfully with university researchers to implement a research program directed to reducing pesticide exposures among the children of migrant farmworkers. The research process has included both qualitative research methods with members of the community and quantitative approaches to measure pesticide dust residues in homes, biomarkers of pesticide exposure, and effects on health. A committee of university and community stakeholders advises the research. Evaluative processes have been initiated to assess the effectiveness of the participatory model used in this project. The components of the preliminary process evaluation and results are presented. Evaluative data show that researchers and community members differ on perceptions of community involvement and the extent to which communication problems have been resolved between the two groups. Suggestions for improved community involvement and communication are given.
Collapse
Affiliation(s)
- L A McCauley
- Center for Research on Occupational and Environmental Toxicology, Oregon Health Sciences University, 3181 SWSam Jackson Park Rd., Portland, OR 97201-3098, USA.
| | | | | | | | | |
Collapse
|
45
|
Acosta F, Moreno J, Fuente T, Diaz J, Sansano T, Palenciano CG, Reche M, Beltran M, Roques V, Robles R, Bueno FS, Ramirez P, Parrilla P. Influence of surgical technique on the plasma concentration of beta-endorphin during liver transplantation. Transplant Proc 2000; 32:2658. [PMID: 11134748 DOI: 10.1016/s0041-1345(00)01828-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- F Acosta
- Liver Transplant Unit, University Hospital "V.Arrixaca,", Murcia, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Merino FJ, Serrano JL, Saz JV, Nebreda T, Gegundez M, Beltran M. Epidemiological characteristics of dogs with Lyme borreliosis in the province of Soria (Spain). Eur J Epidemiol 2000; 16:97-100. [PMID: 10845256 DOI: 10.1023/a:1007690807637] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
From the point of view of the human disease, dogs are the most important animal reservoir of Lyme borreliosis; therefore, they are used as 'sentinel animals'. In order to know the epidemiological characteristics of dogs with antibodies against Borrelia burgdorferi, 146 canine sera samples collected during 1993-94 have been studied. The antibody detection was made by an indirect immunofluorescence method and confirmed by a haemagglutination test. Seventeen dogs (11.6%) were seropositive, of which seven were hunting dogs, three were shepherd dogs, five were domestic pets, one was a watchdog and one was a stray dog. Seven dogs had longhair phenotype, 2 medium length type, 4 hard-hair and the other 4 were short-haired. Twelve seropositive dogs were males and five were females. All seropositive dogs were more than 1 year old. The dogs with greater seroprevalence were those that harboured ticks more often than the rest. Spring and summer were the seasons when more ticks were observed. The seroprevalence found in dogs was similar to that previously obtained in humans in this area. This finding gave evidence to an intimate association between human and canine seroprevalence.
Collapse
Affiliation(s)
- F J Merino
- Servicio de Microbiología Clínica, Hospital General del INSALUD de Soria, Spain.
| | | | | | | | | | | |
Collapse
|
47
|
Fuentes R, Bover I, Rifa J, Moreno V, Canals E, Marquez A, Molina R, Borras I, Beltran M, Viladiu P. Clinical prognostic factors (PF) for survival in non small cell lung cancer (SCLC). Can they add something new? Results of a prospective multicenter study. Eur J Cancer 1997. [DOI: 10.1016/s0959-8049(97)85851-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
48
|
|
49
|
Beltran M, Alcalde R, Aguado E, Massegu M, Dorca J, Cornella J, Herrero L. 876 The experience of a palliative care team linked to an oncology department. Eur J Cancer 1995. [DOI: 10.1016/0959-8049(95)96125-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
50
|
Arredondo JL, Higuera F, Hidalgo H, Narcio L, Casanova G, Beltran M, Sanchez CJ. Clindamycin vaginal cream vs oral metronidazole in the treatment of bacterial vaginosis. Arch AIDS Res 1992; 6:183-95. [PMID: 12317784] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/19/2023]
|